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A B S T R A C T 
Self-renewal requirements of human embryonic stem cells and their engraftment 
potential in mouse blastocysts 
Daylon Jefferson James, Ph.D. 
The Rockefeller University 2006 
Human embryonic stem cells (hESCs) are a unique population of cells derived 
from a 6 day old human embryo that can be maintained indefinitely in vitro and have the 
ability to differentiate to all adult cell types. In addition to their potential for cell based 
therapies in the treatment of disease and injury, the broad developmental capacity of 
hESCs offers potential for studying the origins of all human cell types. Embryonic stem 
cells were first derived from mouse embryos (mESCs), and years of work have 
demonstrated their utility to developmental research, but relatively little is known about 
human ESCs. The experiments described below address two fundamental questions in 
hESC biology: First, what are the molecular signaling pathways that are relevant to hESC 
"sternness"? And second, can hESCs contribute to specialized human cell types in the 
context of mouse embryogenesis? 
Because it plays a prominent role in the early cell fate decisions of embryonic 
development, we examined the role of TGFP superfamily signaling in hESCs. W e found 
that, in undifferentiated cells, the TGFp/activin/nodal branch is activated (through the 
signal transducer Smad2/3) while the BMP/GDF branch (Smadl/5) is only active in 
isolated mitotic cells. Upon early differentiation, Smad2/3 signaling is decreased while 
Smadl/5 signaling is activated. W e next tested the functional role of TGFp/activin/nodal 
signaling in hESCs and found that it is required for the maintenance of markers of the 
undifferentiated state. W e extended these findings to show that Smad2/3 activation is 
required downstream of Wnt signaling, which we have previously shown to be sufficient 
to maintain the undifferentiated state of hESCs. Strikingly, we show that in ex vivo mouse 
blastocyst cultures, Smad2/3 signaling is also required to maintain the inner cell mass 
(from which stem cells are derived). These data reveal a critical role for T G F P signaling 
in the earliest stages of cell fate determination and demonstrate an interconnection 
between T G F P and Wnt signaling in these contexts. 
To date, the emergence of specialized cells from hESCs has commonly been 
studied in tissue culture or upon injection into adult mice, yet these methods have stopped 
short of demonstrating the potential exhibited by mESCs, which can give rise to every 
cell type when combined with embryos at the blastocyst stage. Due to obvious barriers 
precluding the use of human embryos in similar cell mixing experiments with hESCs, 
human/non-human chimeras may need to be generated for this purpose. In order to define 
the developmental potential of hESCs in the context of embryogenesis, w e explored the 
ability of hESCs to engraft into mouse blastocysts. In advance of these cell mixing 
experiments, w e derived a new hESC line, RUE S 1 , and characterized its marker 
expression, functional characteristics and gene expression profiles. Using this new line, 
w e showed that hESCs engrafted into mouse blastocysts, where they, proliferated and 
differentiated in vitro and persisted in mouse/human embryonic chimeras that implanted 
and developed in the uterus of pseudopregnant foster mice. Embryonic chimeras 
generated in this way offer the opportunity to study the behavior of specialized human 
cell types in a non-human animal model. Our data demonstrate the feasibility of this 
approach, using mouse embryos as a surrogate for hESC differentiation. 
G E N E R A L I N T R O D U C T I O N 
Contained within each cell of the human body there is a genetic blueprint for all 
its many parts, from calloused toe to thinking brain. Indeed, all vertebrates come into 
being as a single cell, the fertilized egg, proliferates and differentiates to billions of 
specialized cells that are arranged to make up the adult. This process is called 
embryogenesis and it has been scrutinized for millennia. In 350 BC, Aristotle cracked 
open a chicken egg every day during its three week incubation period and noted the 
formation of major organs over time from a tiny streak. In 1924, Hans Spemann and 
Hilde Mangold ushered in the age of experimental embryology with pioneering work 
defining the "organizer" in amphibian embryos (Spemann, 1918; Spemann, 1921; 
Spemann and Mangold, 1923), findings that were not only revolutionary in their own 
time, but also seminal to our modem understanding that it is the molecular interactions 
between cells that dictate form and fate in vertebrate embryogenesis. And in recent 
decades, scientists have begun to reveal the means by which a conserved genetic 
blueprint can give rise to the complex array of cell types generated during vertebrate 
embryogenesis. 
Between vertebrate species, the dynamics of embryogenesis vary in many 
respects; for example, in mammals, eggs are fertilized within the female and embryos can 
gestate for as many as 22 months (Elephant), while amphibian eggs are laid and fertilized 
in the external environment and can develop to free swimming tadpoles within 36 hours 
(Xenopus laevis). Developmental differences such as these account for considerable 
variety between species, but all vertebrates share similarities in the morphological 
process that establishes the early embryonic body plan (Scialli, 2003). In humans, this 
takes place following implantation into the uterus, when a trilaminar organization of the 
embryo emerges as cells migrate through the primitive streak to form mesoderm (Figure 
1). This process is called gastrulation, and it describes the way in which an unstructured 
early embryo undergoes morphogenetic movements to become organized into three 
primary germ layers - endoderm, mesoderm, and ectoderm. Endoderm is the innermost 
germ layer and gives rise to organs including liver, lungs and pancreas; mesoderm, the 
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Figure 1. Schematic representation of primary germ layers and their derivatives 
before, during and after mammalian gastrulation. (A) Representation of m a m m -
alian blastocyst before and during implantation into uterine epithelium. (B) View of 
prospective human embryo before the onset of gastrulation. (C) Cross-section of 
human embryo during gastrulation showing migration of mesodermal cells through 
the primitive streak. (D) Electron micrograph of mouse embryo during gastrulation 
showing three primary germ layers. (E) Chart describing the emergence of tissue and 
organs from primary germ layers and their derivatives. In all panels, ectoderm is repre-
sented in blue, mesoderm is shown in red and endoderm in yellow. 
(Adapted from UNC Medical School Embryo Images Online) 
derivatives of which include the heart, blood and bone, is the middle germ layer; and 
ectoderm, which gives rise to skin and the central nervous system, is the outermost germ 
layer. All vertebrates begin development by organizing into these three primary germ 
layers, and each layer gives rise to homologous organ systems in evolutionarily related 
species. Hence, by studying animals as distant as frogs, w e can advance our 
understanding of human development. 
During embryogenesis, the emergence of a complete repertoire of tissues from the 
primary germ layers demands a symphony of signaling and gene expression in order to 
coordinate millions of cells. In the same way that morphogenetic movements of the early 
embryo are similar between vertebrate species, the major signal transduction pathways 
that mediate gastrulation are also conserved among vertebrates. In the last half century, 
molecular studies using animal models have revealed many conserved transduction 
pathways that mediate the specification of specialized cell fates/identities during 
vertebrate embryogenesis (Figure 2). Indeed, from situs inversus (reversal of sidedness of 
organ system) to acheiropody (absence of hands and feet), insights into the molecular 
bases of human birth defects have mostly been gained from experiments using animal 
models (Leroi, 2003, p. 114). In these ways, experiments on closely related organisms 
have been invaluable to an understanding of human development and disease, but some 
of the most challenging questions cannot be resolved without the use of bona fide human 
tissue. 
With the emergence of human embryonic stem cells (hESCs) as a resource, 
scientists today are uniquely situated to capitalize on the last century of developmental 
research. hESCs are a population of cells derived from a 6 day old human embryo (Figure 
3) (Thomson et al., 1998). At this stage, the embryo is at the blastocyst stage, a hollow 
sphere with an eccentrically placed clump of cells called the inner cell mass (ICM). 
Embryonic stem cells that are derived from mouse I C M (mESCs) have been shown to 
give rise to any and all cells of the adult mouse (Reviewed in Smith, 2001), and it is 
presumed that hESCs have the same capacity. In fact, the stage from which hESCs are 
derived comes before the specification of primary germ layers via gastrulation, so hESCs 
Figure 2 
Figure 2. Eight developmental^/ relevant signal transduction pathways. Ligands, 
intracellular effectors and transcriptional cofactors that mediate signaling by eight 
canonical signal transduction pathways.These signaling pathways are instrumental 
to much of the intercellular communication during vertebrate embryogenesis. 
(Adapted from Brivanlou and Darnell, Science, 2002) 
Figure 3 
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Figure 3. Schematic representation of the derivation process of human embryo-
nic stem cells from IVF embryos. (A) Human zygotes generated by in vitro fertiliz-
ation are cultured to morula (B) and then blastocyst stages (C) in vitro. (D) The inner 
cell mass of the human blastocyst is isolated and plated on a feeder layer of mouse 
embryonic fibroblasts. (E) Stable cultures of human embyonic stem cells can give 
rise to specialized cell types in vitro, including blood (a), nerve cells (b) and muscle (c). 
(Adapted from University of Wisconsin, Board of Regents, 2001) 
are able to assume endodermal, mesodermal, or ectodermal fates, as well as their 
derivatives. They also have the ability to self-renew and can be maintained for indefinite 
passages in vitro. For these reasons, hESCs offer great potential for the study of human 
development, as well as the treatment of disease and/or injury using cell-based therapies. 
Embryonic stem cells were first discovered in the mouse (mESCs), and for years, 
m E S C s have commonly been used for the introduction of genetic modifications into mice 
and the study of tissue differentiation in vitro. But hESCs were only first derived in 1998 
(Thomson et al, 1998), and many known attributes of m E S C s cannot be extrapolated 
directly to apply to hESCs. Hence the pace of research has been brisk, as scientists race to 
bridge the gap between our understanding of hESCs and their potential. The work 
comprising this doctoral thesis focuses on two related aspects of hESC biology; the first 
section addresses the molecular nature of the undifferentiated state of hESCs: Leukemia 
inhibitory factor (LIF), a cytokine that was shown to maintain self renewal of m E S C s 
(Smith, 2001), does not maintain self renewal of hESCs (Sato et al., 2004). W e describe 
the activation state of another developmentally relevent pathway, the T G F P pathway, in 
undifferentiated hESCs and demonstrate a requirement for Activin/Nodal signaling in the 
maintenance of hESC self-renewal. In the second section, w e examine the capacity of 
hESCs to engraft into blastocyst stage mouse embryos. A significant barrier to the 
exploration of hESC potential is the absence of human embryos in which to examine the 
behavior of engrafted hESCs. Engraftment of hESCs into the mouse blastocyst is a 
potential way of observing their differentiation in an embryonic milieu that approximates 
the environment from which they were derived, the ICM. In the experiments presented 
and discussed below, w e set out to define some molecular aspects of "sternness" and 
explore the potential for non-human embryos to serve as a surrogate for the 
differentiation of hESCs. 
C H A P T E R 1 
Maintaining the Undifferentiated State of Human Embryonic Stem Cells 
Summary 
Human embryonic stem cells self-renew indefinitely and give rise to derivatives 
of all three primary germ layers, yet little is known about the signaling cascades that 
govern their pluripotent character. Because it plays a prominent role in the early cell fate 
decisions of embryonic development, we have examined the role of TGF(3 superfamily 
signaling in hESCs. W e found that, in undifferentiated cells, the TGFp/activin/nodal 
branch is activated (through the signal transducer Smad2/3) while the BMP/GDF branch 
(Smadl/5) is only active in isolated mitotic cells. Upon early differentiation, Smad2/3 
signaling is decreased while Smadl/5 signaling is activated. W e next tested the 
functional role of TGFp/activin/nodal signaling in hESCs and found that it is required for 
the maintenance of markers of the undifferentiated state. W e extend these findings to 
show that Smad2/3 activation is required downstream of Wnt signaling, which we have 
previously shown to be sufficient to maintain the undifferentiated state of hESCs. 
Strikingly, we show that in ex vivo mouse blastocyst cultures, Smad2/3 signaling is also 
required to maintain the inner cell mass (from which stem cells are derived). These data 
reveal a critical role for TGFP signaling in the earliest stages of cell fate determination 
and demonstrate an interconnection between TGFp and Wnt signaling in these contexts. 
Introduction 
Embryonic stem cells (ESCs) are a population of multipotent, self-renewing cells 
that are derived from the epiblast of mammalian blastocyst embryos and that retain this 
developmental identity even after prolonged culture in vitro (Rossant, 2001). ESCs can 
be induced to differentiate to functional cell types of all three primary germ layers in 
vitro, and upon integration into host animals, they have the capacity to contribute to all 
cell types of the embryo, including the germ line (Smith, 2001). These qualities have 
made ESCs valuable resources for the introduction of complex genetic modifications into 
mice; and the isolation and culture of human embryonic stem cells (Thomson et al., 1998) 
has drawn a great deal of attention to their biology and the potential they offer for 
regenerative medicine, as well as the study of early human development. 
Little is known about the signaling pathways that govern the unique properties of 
hESCs. Maintenance of m E S C identity was initially found to be dependent on extrinsic 
factors that were produced by a feeder layer of mouse embryonic fibroblasts (MEFs). 
Subsequently, it was found that leukemia inhibitory factor (LIF) was produced by M E F s 
and was sufficient to maintain ES cell identity in the absence of a feeder layer. LIF, 
however, is not the lone factor responsible for the maintenance of stem cell identity in the 
mouse, as null mutants in which LIF/Stat3 signaling is eliminated show no defect in the 
establishment of the stem cell compartment (reviewed in Smith, 2001). Furthermore, LIF 
is incapable of maintaining stem cell identity in hESCs (Thomson et al, 1998, Reubinoff 
et al, 2000, Sato et al, 2004), suggesting a contribution from other signaling pathways to 
the establishment and/or maintenance of stem cell identity in mammalian development. 
Reports have linked at least two other transduction pathways to the maintenance of the 
undifferentiated state. Recent work has shown that the undifferentiated state of hESCs 
can be maintained in the absence of M E F s by two methods: activation of the Wnt 
pathway by BIO, a small bioactive molecule that inhibits G S K 3 P (Sato et al., 2004); or 
culture in high concentrations of F G F (Xu et al., 2005). But at present, hESCs can only 
be reliably and consistently maintained undifferentiated through culture in the presence 
of unknown factors in MEF-conditioned medium. 
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Assuming hESCs have a cognate population in a developing human embryo, the 
identity of stem cells may be rooted in the molecular environment found in early 
embryogenesis. That is, the transduction pathways that dictate cell identity in the embryo 
may also be involved in stem cell maintenance in vitro. Models of early vertebrate 
development have described a role for multiple signaling cascades in the emergence of 
pattern and cell identity (Harland and Gerhart, 1997; Scialli, 2003). These models have 
suggested a prominent role for TGFP signaling in the earliest cell fate decisions of 
embryogenesis (Figure 4). For example, in the amphibian Xenopus leaevis, the TGFP 
pathway is implicated in neural induction and mesendoderm specification, two of the 
earliest developmental events (reviewed in Munoz-Sanjuan and Brivanlou, 2002); and it 
is also involved in primitive streak and mesoderm formation in the mouse (reviewed in 
Goumans and Mummery, 2000). 
The TGFP superfamily, which contains approximately 40 potential ligands in the 
human genome, signals through two main branches (Figure 5): The bone morphogenetic 
protein (BMP)/growth and differentiation factor (GDF) ligands account for one branch; 
and transforming growth factor beta (TGFP)/Activin/Nodal ligands comprise the second 
branch. Upon receptor activation, TGFP signals are conveyed to the nucleus by Smad 
proteins. Smadl and Smad5 transduce on behalf of B M P and GDF ligands via the type I 
receptors A L K 1, 2, 3, and 6; and the TGFp/Activin/Nodal branch is transmitted by 
Smad2 and Smad3 via A L K 4, 5 and 7 (reviewed in Shi and Massague, 2003). There are 
also two inhibitory Smads that provide a repressive input on the pathway; Smad6, which 
selectively inhibits Smadl/5; and Smad7, which inhibits both branches of TGFP 
signaling. And finally there is the common Smad, Smad4, which is an accessory Smad 
that binds receptor activated Smadl/5 or Smad2/3. Upon activation by phosphorylation 
and association with a common Smad4, the receptor activated Smads translocate to the 
nucleus and, in concert with other transcription factors, regulate gene expression (Shi and 
Massague, 2003). 
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Figure 4. TGFP signals figure prominently in early cell fate decisions 
during vertebrate development. (A) Expression patterns of Nodal-related 
genes within the TGFP superfamily (red hatching) are superimposed on 
simplified fate maps of early frog and fish embryos. Classical embryological 
studies have shown that the vegetal region in frog and fish embryos is the 
source of mesoderm-inducing factors. Nodal-related genes are experessed 
in these regions. (B) A schematic representation of an early mouse embryo at 
5.5 and 6 days post-coitus shows a model of Nodal action. At 5.5 dpc Nodal is 
expressed in the mouse epiblast and is maintained and enhanced by auto-
regulation. Nodal signaling induces leftyl and cerl in the distal visceral endo-
derm. Nodal signaling is required for the displacement of anterior visceral 
endoderm, determining the position of the anterior-posterior axis by 6 dpc. 
(Adapted from Schier and Shen, Nature 2000; and Schier, AnnuRevCellBio, 
2003) 
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Figure 5 
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Figure 5. Extra a n d Intracellular c o m p o n e n t s of the T G F P signaling pathway. 
T G F P ligands signal to the nucleus via t w o distinct branches.The Activin/Nodal 
branch (left) signals via Activin, Nodal and T G F P ligands which bind receptors at 
the cell m e m b r a n e , resulting in phosphorylation of the effector S m a d s 2 and/or 3. 
T h e B M P / G D F branch (right) signals via B M P and G D F ligands which bind recep-
tors, resulting in phosphorylation of S m a d s 1/5 and/or 8. U p o n phosphorylation, 
effector S m a d s from both branches bind S m a d 4 and accumulate in the nucleus, 
w h e r e they collaborate with transcriptional co-factors to drive g e n e expression. 
There are also inhibitory S m a d s 6 and 7, which apply a repressive input o n the 
accumulation of effector S m a d s in the nucleus. 
(Adapted from Munoz-Sanjuan and Brivanlou, Nature Neuro Reviews, 2002) 
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Here w e show that activation of the Activin/Nodal branch through Smad2/3 is 
associated with pluripotency and is required for the maintenance of the undifferentiated 
state in hESCs and in ex vivo mouse blastocyst outgrowths. Whether hESCs were 
maintained in MEF-conditioned medium or BIO, w e show that Activin/Nodal signaling is 
required downstream of both conditions, in that inhibition of this pathway with a small 
molecule inhibitor or soluble receptors results in a loss of the undifferentiated state. 
Accordingly, we find that exogenous ActivinA is supportive of the undifferentiated state. 
In our study of hESCs, w e have revealed a critical role for T G F P signaling in the 
regulation of ES cell identity. 
14 
Results 
The undifferentiated state of hESCs is characterized by activation of Smad2/3 
signaling and inhibition of Smadl/5 signaling 
While TGFP signaling has been shown to play a role in primary cell fate decisions 
in many developmental models, its role in E S C fate determination remains uncertain. To 
study the involvement of the T G F P superfamily pathway in E S C fate decisions, w e first 
analyzed the activation status of both arms of this family (TGFp/activin/nodal signaling 
and B M P / G D F signaling) in human embryonic stem cells, both in the undifferentiated 
state and during the early phase of differentiation in response to certain modulators of 
T G F P superfamily activation (Figure 6). 
In the undifferentiated state that is maintained by growth in MEF conditioned 
medium (CM), we found that Smad2/3 was phosphorylated and localized to the nucleus 
of hESCs, indicating activation of the TGFp/activin/nodal pathways. Furthermore, the 
phosphorylation and nuclear localization were both reduced in cells that were allowed to 
differentiate by growth in non-conditioned medium (nCM) (Figure6A and B). W e have 
previously shown that the G S K 3 P inhibitor BIO is also capable of maintaining hESCs in 
the undifferentiated state, even in the absence of C M , through activation of canonical 
Wnt signaling (Sato et al, 2004). Accordingly, BIO maintained phosphorylation of 
Smad2/3 above levels seen in hESCs grown in n C M alone, and this effect was 
accompanied by maintenance of Oct3/4, a marker of pluripotency. To test the ability of 
hESCs cultured in n C M to activate Smad2/3 signaling, w e cultured the cells in n C M 
supplemented with ActivinA. Under these conditions, hESCs maintained high levels of 
Smad2/3 phosphorylation as well as increased Oct3/4 relative to cells cultured in n C M 
alone, though morphologically, cells were not identical to undifferentiated hESCs. These 
results suggest that Smad2/3 activation in the absence of extrinsic factors present in C M 
may be supportive of the undifferentiated state, though not entirely sufficient to maintain 
typical hESC morphology nor markers of pluripotency through extended culture (Figure 
6A-C). 
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Figure 6. The undifferentiated state of hESCs is characterized by activation of Smad2/3 
mediated signal transduction and inhibition of Smadl/5 mediated signal transduction. 
(A)Westem blot analysis of HI hESCs cultured in various conditions. Cells were cultured for 
four days in the presence of nCM supplemented with 2 uM BIO, non-conditioned medium 
(nCM),MEF conditioned medium (CM), C M supplemented with 25 ng/ml BMP4and nCM 
supplemented with 25 ng/ml ActivinA. Membranes were probed with antibodies specific 
for phosphorylated Smad2, Smad2/3, phosphorylated Smad 1/5, Smad 1/5,Oct3/4 and ot-tub-
ulin (as a control for protein loading). (B) Immunofluorescence microscopy of BGN2 hESCs in 
the undifferentiated and differentiated state. BGN2 cells were cultured for 5 days in the pres-
ence and absence of CM, in nCM supplemented with 25 ng/ml ActivinA and with nCM supp-
lemented with 2uM BIO.Cells were decorated with an antibody specific for Smad2/3,as well 
asSytoxGreen nuclear counterstain. (C) Brightfield images of H1 hESCs cultured in conditions 
described for panel (A). All scale bars represent 50 urn. 
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W e also examined the state of Smadl/5 phosphorylation in hESCs grown in the 
above conditions. Smadl/5 activation in these cells showed the opposite character of 
Smad2/3 activation; in the undifferentiated state, Smadl/5 phosphorylation was barely 
evident and upon differentiation, phosphorylation was globally increased and localized to 
the nucleus (Figure 6 A and 7A). Addition of ActivinA to n C M reduced phosphorylation 
of Smadl/5 to levels comparable to those of hESCs grown in C M , suggesting an input of 
Smad2/3 mediated signaling on the suppression of Smadl/5 activation. To study the 
effect of induced Smadl/5 activation in undifferentiated hESC, we cultured cell in C M 
supplemented with B M P 4 . As previously reported (Xu et al, 2002b), these conditions 
resulted in a decrease in Oct3/4 levels and a concomitant change in morphology (Figure 
6A,C). Thus, w e have shown that Smad2/3 activation correlates with sternness in hESCs 
descriptively and functionally, while Smadl/5 activation correlates with differentiation. 
Minimal global levels of Smadl/5 phosphorylation in undifferentiated hESCs 
may be accounted for by the observation that phosphorylation was only evident in the 
cytoplasm of cells undergoing mitosis (arrows in Figure 7A). In order to assess the 
relationship between Smadl/5 phosphorylation and mitotic index, hESCs were 
synchronized by incubation with colcemide, which arrests cells at the onset of metaphase. 
Smadl/5 phosphorylation was compared between hESCs that had been released from the 
colcemide block for different lengths of time and asynchronous hESCs (Figure 7B). 
hESCs that were released from colcemide block for 15 minutes showed higher levels of 
Smadl/5 phosphorylation than hESCs that had been released for 4 hours. Asynchronous 
hESCs show slightly reduced levels relative to cells that had been blocked and released 
for 15 minutes. To measure the efficacy of colcemide in hESCs synchronization, w e used 
an antibody which is specific for phospho-serines on C D K s that are phosphorylated only 
in the context of mitosis. B M P stimulated hESCs were used as a control for Smadl/5 
phosphorylation. Interestingly, a correlation between Smadl/5 phosphorylation and 
mitotis was also apparent in dividing cells of preimplantation mouse embryos (Figure 
7C). 
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Figure 7.Global Smadl/5 phosphorylation is increased under differentiation conditions and is 
evident in mitotic hESC in the undifferentiated state. (A) Immunofluorescence microscopy of BGN2 
hESCs in the undifferentiated and differentiated state. BGN2 cells were cultured for 5 days in the pres-
ence and absence of CM, in CM supplemented with 25 ng/ml BMP4 as a control for Smadl/5 activation 
and nCM supplemented with 2 uM BIO. Cells were decorated with an antibody specific for phosphor-
ylated Smadl IS, as well as SytoxGreen nuclear counterstain. Arrows indicate mitotic cells. Scale bars 
represent 50 urn. (B) Western blot analysis of colcemide synchronized BGN1 hESCs. Cells were blocked 
at metaphase by incubation with 100 ng/ml demecolcine solution and harvested at 15 minutes and 4 
hours post-release. Cells grown in C M alone and C M supplemented with 25 ng/ml BMP4 were used as 
controls for asynchronous and Smadl/5 activated cells, respectively. Membranes were probed with 
antibodies specific for phosphorylated Smad 11S, Smad 11S, phosphorylated Ser CDKs substrate, and 
oc-tubulin (as a control for protein loading). (C) Immunofluorescence microscopy of blastocyst stage 
embryo containing mitotic cells. Mouse blastocyst embryos were fixed and decorated with anti-phospho 
Smad1/5 antibody and SytoxGreen nuclear counterstain and then imaged by confocal microscopy. Scale 
bars represent 20 urn. 
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Smad2/3 activation is necessary for maintenance of the undifferentiated state in 
hESCs 
Having defined the nature of Smadl/5 and Smad2/3 activation in undifferentiated 
and differentiating hESC, and having discovered a correlation between increased 
Smad2/3 activation and the undifferentiated state, w e set out to determine whether active 
Smad2/3 signaling is necessary for the maintenance of the pluripotent state (Figure 8). 
The TGFp/Activin/Nodal branch of T G F P signaling can be efficiently inhibited by SB-
431542, a synthetic compound that precludes Smad2/3 phosphorylation by type 1 T G F P 
receptors (Laping et al, 2002). W e challenged hESCs cultured in the presence of C M or 
BIO with SB-431542. As expected, phosphorylation of Smad2/3 is reduced in hESCs 
cultured in the presence of SB-431542 and the ability of C M or BIO to maintain protein 
levels of the pluripotency marker, Oct3/4, was lost upon challenge with SB-431542. In 
addition to reducing Smad2/3 phosphorylation and Oct3/4, SB-431542 also has the effect 
of increasing Smadl/5 phosphorylation to the levels seen in differentiating hESCs 
(Figure8A). 
Prompted by the result that intact Smad2/3 signaling was necessary for the 
maintenance of high Oct3/4 protein levels in hESCs, w e examined the expression of 
known markers of pluripotency in hESCs with the variable levels of Smad2/3 activation 
described above (Figure 8B). Upon withdrawal of C M and the subsequent reduction of 
Smad2/3 phosphorylation, hESCs showed reduced expression of Oct3/4 as well as 
another established marker of pluripotency, Nanog. Inhibition of Smad2/3 activation by 
SB-431542 in the presence of C M or BIO resulted in significantly reduced expression of 
both markers. Consistently, SB-431542 promoted differentiation by morphological 
criteria, inducing cells to assume a flat, spread out morphology (Figure 8C). Stimulation 
of TGFp/Activin/Nodal signaling by ActivinA in the presence of n C M restored the 
expression of both markers to levels above those exhibited by hESCs cultured in n C M 
alone. Hence, by measure of two independent markers of pluripotency, Smad2/3 
activation is not only necessary to, but also supportive of the undifferentiated state of 
hESCs. 
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Figure 8. Intact Smad2/3 signaling is required for the maintenance of the undifferentiated state in hESCs. 
(A)Western blot analysis of H1 hESCs cultured in conditions in which Smad2/3 signaling is intact or inhibited. 
Cells were cultured for 4 days in the presence of CM, C M supplemented with 1OuM SB-431542, nCM supplemented 
with 2 uM BIO,and nCM supplemented with 2 uM BIO and 10 uM SB-431542. Membranes were probed with anti-
bodies specific for phosphorylated Smad2, Smad2/3, phosphorylated Smad 1/5, Smad 1/5, Oct3/4 and oc-tubulin 
(as a control for protein loading). (B) Expression analysis of H1 hESCs. Cells were cultured for 4 days in CM, nCM, nCM 
supplemented with 25 ng/ml ActivinA, CM supplemented with 25 ng/ml BMP4,CM supplemented with 10 u M SB-
431542, nCM supplemented with 2 uM BIO,and nCM supplemented with 2 uM BIO and 10 nM SB-431542. RT-PCR 
was performed on these cells using primers for human Oct3/4, Nanog, p-actin (as a loading control) and p-actin RT 
minus (as a control for contamination with genomic DNA). (C) Brightfield views of hESCs cultured in conditions 
described in panels A and B. Scale bars -50um (D) Western blot analysis of H1 hESCs cultured in the presence of a 
cocktail of soluble receptors specific to the Activin/Nodal pathway. Cells were cultured for 5 days in the presence 
of CM,nCM,CM supplemented with 10 uM SB-431542 and C M supplemented with hrActRIB (5 ug/ml), hrActRIIB 
(5 ug/ml) and hrCripto (250 ng/ml). Membranes were probed with antibodies specific for phosphorylated Smad2, 
Oct3/4, Nanog and a-tubulin (as a control for protein loading). 
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W e next set out to confirm that our observations concerning the effect of SB-
431542 were specific to its inhibition of Activin/Nodal signaling through Smad2/3. Small 
molecule inhibitors have tremendous experimental value because they allow strict 
temporal and dose-dependent control of their effect and can traverse most, if not all, 
compartments of a cell, but they also have the potential to affect unrelated signal 
transduction pathways. In order to rule out the possibility that SB-431542 was mediating 
its effect by disrupting signal transduction unrelated to the T G F P superfamily, w e used an 
independent means of inhibiting Activin/Nodal signaling, culturing hESCs in C M 
supplemented with a combination of human recombinant ActRIB, hrActRIIB, and 
hrCripto (Figure 8D). These three proteins in their native state form a complex and bind 
Activin/Nodal ligands in canonical T G F P signaling, so soluble extracellular domains 
should provide an alternative to SB-431542 by competing for Activin/Nodal in C M . Both 
Oct3/4 and Nanog were significantly reduced in hESCs cultured in the presence of 
soluble receptors (Figure 8D), thus providing corroborative data demonstrating the 
requirement for this pathway in the maintenance of pluripotent hESCs. 
Our results indicated that the negative effect of SB-431542 on maintenance of 
hESC pluripotency is specific to canonical T G F P signaling, but this pathway is involved 
in many of the more fundamental aspects of cell biology, including cell viability, 
adhesion, migration and proliferation (reviewed in Massague et al, 2000). Thus, the 
global inhibition of Alk4/5/7 activation by SB-431542 could be affecting the fundamental 
cellular biology of hESCs in a manner independent of differentiation pathways. In order 
to address whether SB-431542 was affecting cell viability or proliferation of hESCs, w e 
performed Brdu incorporation and T U N E L assays (Figure 9A) and found no significant 
effect of SB-431542 on these parameters. 
Apart from its role in activating the TGFp/activin/nodal branch of TGFP 
signaling, Alk4/5/7 has also been implicated in activation of M A P kinases, including p38, 
Jnk, and Erk. It has previously been shown that, at the doses we have used, SB does not 
significantly affect activation of other pathways in cell culture (Inman et al, 2002). To 
confirm this in hESCs, we assessed the phosphorylation of M A P kinases p38, JNK, and 
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Figure 9. Effect of SB-431542 is not due to alterations in hESC viability 
or related Alk4/5/7 receptor mediated signal transduction (A) Histogram 
describing Brdu incorporation and TUNELassays performed on HI hESCs. 
Cells were cultured for 3 days (except when indicated otherwise) in the pres-
ence of CM, nCM, C M with 10 uM SB-431542, nCM with 2 u M BIO and nCM 
with 2 uM BIO and 10 uM SB-431542. Brdu incorporation and TUNEL assays 
were performed on three successive passages of HI hESCs. (B) Western blot 
analysis of HI hESCs cultured in conditions shown. Cells were cultured for 
2 or 24 hours in the presence of nCM supplemented with 25ng/ml ActivinA, 
CM, C M supplemented with IOuM SB-431542 and nCM supplemented with 
2uM BIO with or without 10uM SB-431542. Membranes were probed with 
antibodies specific for phosphorylated forms of Smad2,p38, Jnk and Erk1,as 
well as a-tubulin (loading control). 
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Erk in the presence and absence of SB-431542 and found that the phosphorylation of 
these effector molecules was not regulated upon addition of SB-431542 (Figure 9B). 
Due to the high passage number of the HI hESC line used, it is possible that the 
cells may have acquired an abnormal karyotype that endowed it with an atypical 
character. In order to exclude this possibility, the cells used in these experiments were 
karyotyped and found to have a normal complement of chromosomes (data not shown). 
Embryoid body formation is inhibited in SB-431542 treated hESCs 
Embryonic stem cells are defined functionally by their pluripotency - the ability to 
give rise to cell types representing all three primary germ layers of the embryo. In 
examining the necessity for Smad2/3 signaling in the maintenance of the pluripotency, it 
is important to assay the properties of hESCs in conditions that more closely approximate 
in vivo conditions. There are currently two "in-vivo" assays for hESCs: teratoma 
formation in immuno-compromised mice and formation of embryoid bodies in culture 
(Thomson et al., 1998). Embryoid bodies are formed from undifferentiated hESC 
aggregates cultured in suspension and they typically contain differentiated cell types of 
ectodermal, mesodermal and endodermal lineages. Differentiated hESCs do not form 
embryoid bodies. 
We examined the efficiency of embryoid body formation from hESCs cultured for 
four days under condtions in which Smad2/3 signaling was activated or inhibited (Figure 
10A). Addition of the inhibitor SB-431542 to cells grown in C M significantly reduced 
the number of embryoid bodies that formed. Cells grown in the presence of BIO were 
able to form more embryoid bodies than cells grown in n C M alone, and these embryoid 
bodies were similar morphologically to those formed from hESCs grown in C M (Figure 
10B). This effect was drastically reduced in the context of Smad2/3 inhibition and the 
few embryoid bodies that did form were of an atypical, multi-cystic morphology (Figure 
10B). Activation of Smad2/3 alone by ActivinA conferred upon the cells a marginally 
increased ability to generate embryoid bodies, which is consistent with the ability of 
ActivinA to restore Oct3/4 levels in cultured hESCs. These data support the notion that 
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Figure 10. Inhibition of Smad2/3 signaling adversely affects the ability of hESCs to 
form embryoid bodies. (A) Histogram describing number of embryoid bodies formed 
from BGN2 hESCs.Cells were cultured for 7 days in CM, nCM, nCM with 25 ng/ml ActivinA, 
C M with 10 uM SB-431542, nCM with 2 uM BIO and nCM with 2 u M BIO and 10 uM SB-
431 542. Cells were then detached from substrate and cultured in a suspension of nCM 
for 7 days further. Histograms and error bars represent the experiment performed in 
triplicate and on two separate passages of BGN2 cells. (B) Brightfield images of embryoid 
bodies formed under the conditions represented in the histogram in (A). 
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Smad2/3 activation is necessary but only partially sufficient for maintenance of 
pluripotency. 
In order to assess the character of embryoid bodies formed from hESCs cultured 
in the above conditions, we assayed the differentiated cell types contained within them by 
RT-PCR and found that markers of all three primary germ layers were expressed (data 
not shown). 
Smad2/3 activation is not necessary for maintenance of the undifferentiated state in 
mESCs 
Having found the same requirement for active Smad2/3 signaling in three 
independent hESC lines (data not shown), we next assayed the relevance of Smad2/3 
activation to mESC identity. mESCs are typically cultured in medium containing 
leukemia inhibitory factor (LIF), a protein that has been shown to maintain the 
undifferentiated state of mESCs (Smith, 2001), but not hESCs (Thomson et al, 1998, 
Reubinoff et al, 2000, Sato et al, 2004). However, a role for LIF in the establishment and 
maintenance of the mouse stem cell compartment in vivo is uncertain, as null mutants for 
components of the LIF/Stat3 pathway have no stem cell defect (Smith, 2001). W e 
examined the nature of Smad2/3 signaling in mESCs with the expectation that the 
necessity for Smad2/3 signaling in mESCs cultured in medium containing LIF would be 
similar to that observed for hESCs cultured in M E F conditioned medium (Figure 11 A). 
mESCs were cultured in defined medium without a contribution of growth factors 
from serum. Upon withdrawal of LIF, levels of Smad2/3 phosphorylation in mESCs were 
reduced, but the SB-431542-mediated inhibition of Smad2/3 signaling in the context of 
LIF resulted in no significant change in Oct3/4 levels. W e have previously shown that 
BIO is able to maintain mESCs as well as hESCs in the undifferentiated state (Sato et al, 
2004). In support of this result, mESCs grown in the presence of BIO were able to 
maintain levels of Oct3/4 relative to mESCs cultured in the presence of LIF, but 
unexpectedly, inhibition of Smad2/3 signaling in the context of BIO had no effect on 
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Figure 11. Intact Smad2/3 signaling is not required for the maintenance of the undifferentiated state of 
mESCs, but is required for the maintenance of the stem cell compartment of blastocyst outgrowths. 
(A) Western blot analysis of 129/SVJ mESCs. mESCs were cultured for 3 days in mESC medium with and without 
LIF, mESC medium with LIF plus 10 u M SB-431542, mESC medium with 25 ng/ml ActivinA, mESC medium with 
2 u M BIO, mESC medium with 2 u M BIO plus 10 u M SB-431542, CM, C M with 10 u M SB-431542. Membranes 
were probed with antibodies specific for phosphorylated Smad2,Smad2/3,Oct3/4 and a-tubulin (as a control 
for protein loading). (B) Whole mount immunofluorescent confocal microscopy of pre-implantation stage 
mouse embryos. Mouse embryos were extracted and fixed at 2 cell, 4 cell, 8 cell, compacted morula and blasto-
cyst stages. Embryos were decorated with an antibody specific for phosphorylated Smad2 and SytoxGreen 
nuclear counterstain. Scale bars represent 20 urn. (C) Confocal immunofluorescent microscopy of blastocyst 
outgrowths. Mouse blastocyst stage embryos were extracted and cultured in the presence of mESC medium 
supplemented with D M S O or 20 u M SB-431542 for 4 days.Outgrowths were decorated with an antibody specific 
forOct3/4 and SytoxGreen nuclear counterstain.The table indicates the percentage of embryos exhibiting 
Oct3/4 positive cells. Scale bars represent 100 urn. 
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Oct3/4 levels (Figure 11 A ) . Taken together, these results suggest that m E S C s are 
dissimilar to hESCs in that they have no requirement for active Smad2/3 signaling in the 
maintenance of pluripotency. Furthermore, the ability of BIO to maintain the 
undifferentiated phenotype of these cells is dependent on active Smad2/3 signaling in 
hESCs but not in mESCs. 
Activation of Smad2/3 is required for maintenance of pluripotency in the ICM of 
mouse blastocyst outgrowths 
The behavior of embryonic stem cells in vitro is obviously different from that of a 
developing embryo in vivo, and the character of m E S C s does not necessarily reflect that 
of their founder population in the I C M of the mouse blastocyst. So the fact that T G F p 
signaling seems to be negligible for the maintenance of pluripotency in m E S C s is no 
indication as to the requirement for T G F P signaling in peri-implantation mouse embryos. 
T G F p ligands and receptors are expressed very early in mouse preimplantation embryos 
(Albano et al, 1993; M u m m e r y et al, 1993; Paria and Dey, 1990; Roelen et al, 1994; 
Slager et al, 1991), and a recent report showed that genetic deletion of both Smad2 and 
Smad3 results in reduced epiblast and Oct3/4 levels in mouse embryos at embryonic day 
7.5 (Dunn, et al, 2004). This prompted us to investigate the requirement for Smad2/3 
activation in the maintenance of the stem cell compartment of mouse blastocysts. Mouse 
blastocyst outgrowths are used to assess the character and potency of two cell types 
present in blastocyst stage embryos, the trophectoderm and inner cell mass (ICM). W h e n 
cultured ex vivo, the trophectoderm cells of the blastocyst adhere to the matrix substrates 
and migrate across them, while the inner (ICM) maintains a compact morphology. It is 
the inner cell mass from which pluripotent embryonic stem cells are derived, and only 
these cells maintain Oct3/4 expression upon outgrowth. 
In order to assess the state of Smad2/3 activation in early mouse development, we 
performed confocal immunofluorescence microscopy on mouse embryos from two-cell to 
late blastocyst stages (Figure 11B). Smad2/3 was phosphorylated and localized to the 
nucleus beginning at the four cell stage and remained phosphorylated in both the 
trophectoderm and I C M up to the blastocyst stage. To assess the requirement for 
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Smad2/3 activation in peri-implantation mouse embryos, w e cultured blastocyst stage 
embryos for 4 days in the presence or absence of SB-431542. W e assayed the presence of 
Oct3/4 in outgrowths cultured from the blastocyst stage for 4 days, both in the presence 
and absence of SB-431542 and found that 7 4 % of control outgrowths (14 of 19) were 
positive for Oct3/4 staining while only 2 9 % of SB-431542 treated outgrowths (6 of 21) 
showed Oct3/4 staining; typical control and SB-431542 treated embryos in which the 
Oct3/4 compartment is maintained and lost, respectively, are represented in Figure 11C. 
Strikingly, while Oct3/4 protein is present in a majority of outgrowths cultured for 4 days 
in the presence of D M S O , most of those cultured in SB-431542 display a complete loss 
of Oct3/4 staining. Hence, Smad2/3 activation is required not only for maintenance of 
pluripotency of hESC cultured in vitro, but it is also required for the maintenance of the 
Oct3/4 positive compartment of the I C M upon blastocyst outgrowth. Mouse blastocyst 
outgrowths cultured in the presence of the soluble receptors hrActRIB, hrActRIIB and 
hrCripto showed a similar trend to those cultured in the presence of SB-431542, with 
3 3 % (8 of 24) containing an Oct3/4 positive compartment. 
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Discussion 
For embryonic stem cells to realize their potential in clinical applications, it is 
first necessary to address fundamental questions regarding their biology and the 
molecular nature of "sternness." W e demonstrate here a requirement for the 
TGFp/activin/nodal branch of the T G F p signaling pathway in the maintenance of human 
embryonic stem cell identity. Either in the context of unknown extrinsic factors secreted 
by M E F s ( C M ) or the G S K 3 inhibitor BIO, inhibition of Smad2/3 activation results in 
significantly reduced expression of markers of pluripotency. While it may contribute to 
the maintenance of the undifferentiated state, Smad2/3 activation alone does not confer 
upon hESCs the stem cell identity. Indeed, Wnt and TGFp/activin/nodal signaling 
collaborate in the maintenance of pluripotency, and the Wnt signaling pathway impinges, 
directly or indirectly, on Smad2/3 activation. W e also found a similar requirement for 
Smad2/3 signaling in the maintenance of the stem cell compartment of cultured mouse 
blastocyst outgrowths, though activated Smad2/3 does not seem to be necessary for the 
ability of LIF to maintain the undifferentiated state of mESCs. 
The primary cell fate decision of mammalian development occurs in morula stage 
embryos when the outer cells of the embryo form trophectoderm, which mediates 
attachment and implantation into uterine tissue, and the inner cells form the inner cell 
mass, which contributes to all the tissues of the embryo and from which embryonic stem 
cells are derived (reviewed in Rossant, 2001). Our results indicate a role for T G F p 
signaling in the maintenance of pluripotency of the cellular derivatives of the inner cell 
mass. While T G F p superfamily ligands have been shown to contribute to primary cell 
fate determination in other vertebrate models, such as the establishment of the dorsal 
organizer in Xenopus (Harland and Gerhart, 1997), an input for TGFps in mammalian 
embryogenesis has not been well described at pre-gastrula stages. Studies of ligand and 
receptor expression suggest that the T G F p cascade is activated in pre-implantation mouse 
embryos (Albano et al, 1993; Paria et al, 1992; de Sousa Lopes et al, 2003) and our 
analysis of Smad2 phosphorylation at these stages showed Smad2/3 activation as early as 
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the four-cell stage. Yet the role of the T G F p superfamily in early mammalian 
embryogenesis is not well understood. 
Previous analyses of the role of TGFp signal transduction in early mammalian 
embryogenesis have mostly arisen from the study of knockout mice. A n array of null 
mutations of T G F P signaling components have been made in the mouse, but among 
these, very few have an effect before gastrulation and none affect the establishment 
and/or maintenance of the stem cell compartment at peri-implantation stages (reviewed in 
Goumans and Mummery, 2000). For example, null mutants of Smad2 or the 
Activin/Nodal receptor ActRIIB result in failure of mesoderm formation and malformed 
primitive streak (Weinstein et al, 1998; Song et al, 1999). Recently, mice were created 
with null mutations for both Smad2 and Smad3 (Dunn et al, 2004). These mice displayed 
a similar, though more severe developmental phenotype to Smad2 null mutants, with 
complete failure to form mesoderm or gastrulate. A striking character of these embryos 
was the loss of pluripotent epiblast by e7.5, as measured by Oct3/4 expression, while the 
formation of extraembryonic ectoderm was retained. In that extraembryonic ectoderm 
arises from trophectoderm (Nagy et al, 2003), this double mutant phenotype supports the 
notion that proper maintenance of the ICM/epiblast requires an intact Smad2/3 signaling 
pathway, as derivatives of this compartment are lost while trophectodermal derivatives 
are able to form. The double mutant phenotype also agrees with our finding that the 
Oct3/4 positive compartment of blastocyst outgrowths is lost, at the equivalent of 
embryonic day 7.5, when Smad2/3 signaling is globally inhibited (Figure 11C). From 
these data, in combination with our results describing the necessity for Smad2/3 signaling 
in maintenance of the undifferentiated state of hESCs, a paradigm emerges in which 
Smad2/3 signaling plays a role in the maintenance of pluripotent cell types in vivo as well 
as in vitro. 
Mice deficient for Smad4, the common Smad that mediates translocation of 
effector Smads to the nucleus, display a similar phenotype to the Smad2/3 double 
knockout, failing to gastrulate or form mesoderm, though Oct3/4 expression in the 
epiblast of these embryos has not been examined (Sirard et al, 1998). It will be interesting 
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to see whether markers of pluripotency are affected for this and related phenotypes, both 
in vivo and upon blastocyst outgrowth. Indeed, many of the null mutations of T G F p 
superfamily ligands and receptors should be reconsidered with respect to their effect on 
the epiblast. 
TGFp signaling has recently been shown by many studies to figure prominently in 
the maintenance of the undifferentiated state of hESCs. A m o n g the factors found to be 
specifically enriched in undifferentiated hESCs are nodal (Rosier et al, 2004), cripto, 
lefty-A and lefty-B (Sato et al, 2003), all components of T G F p signal transduction; cripto 
encodes an EGF-CFC co-receptor that is essential for responsivity to Nodal, and LeftyA 
and LeftyB are both inhibitors of Nodal signaling. Expression of Nodal and both Lefties 
has been shown to be high in undifferentiated hESCs and reduced upon differentiation 
(Besser, 2004), and hESCs cultured in recombinant Nodal exhibit prolonged expression 
of pluripotency markers (Vallier et al, 2004). Furthermore, T G F p has recently been 
shown to contribute to a cocktail of growth factors that maintain the undifferentiated state 
of hESCs in feeder-free culture (Amit et al, 2004) and Smadl/5 activation by B M P 4 is 
known to induce trophectoderm in the context of C M (Xu et al, 2002b). Our results 
extend the role of the T G F p pathway in the maintenance of the undifferentiated state of 
hESCs, demonstrating a requirement for the Activin/Nodal branch downstream of 
canonical Wnt activation or extrinsic factors present in C M . And following from our 
work, Vallier et al. have recently demonstrated a requirement for active Smad2/3 
signaling in the maintenance of hESC pluripotency mediated by high concentrations of 
F G F (Vallier et al, 2005). 
The correlation between Smadl/5 phosphorylation and mitosis we have described 
suggests a compelling role for ligands of the B M P / G D F branch of the T G F p superfamily 
in cell proliferation. This pathway has been linked to cell proliferation in other 
developmental contexts. For example, in Drosophila, overexpression of the B M P 4 
homologue dpp promotes primordial germ cell (PGC) proliferation and causes 
accumulation of more PGCs in the Drosophila gonad (Xhu arid Zie, 2003). In mice, null 
mutations of Alk3, the type I T G F p receptor that mediates Smadl/5 activation, exhibit 
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reduced cell proliferation in the epiblast (Mishina et al, 2002). In light of these 
phenotypes, it is not surprising to see that mitosis in two further developmental contexts 
(pre-implantation mouse embryos and undifferentiated hESCs) is coincident with 
Smadl/5 phosphorylation, yet there is no evidence to support any causal link between the 
two. 
That Smad2/3 signaling is not required for the LIF or BlO-mediated maintenance 
of the undifferentiated state of m E S C s underscores the dissimilarity between hESCs and 
mESCs. LIF is sufficient to maintain pluripotency and self-renewal of mESCs, but these 
cells differentiate when cultured with LIF in the absence of serum (Ying et al, 2003), 
suggesting a necessary input from other extrinsic factors. It has recently been shown that 
m E S C identity can be maintained in cells cultured in the absence of serum, as long as LIF 
is supplemented with either B M P 4 or the forced expression of the downstream B M P 4 
target, Id (Ying et al, 2003). This suggests an essential contribution from the T G F p 
superfamily to the maintenance of mESCs, though this contribution activates the 
Smadl/5 signaling cascade that induces differentiation to trophectoderm when it is 
activated in hESCs (Xu et al., 2002b). Considering the disparity between our results 
describing the necessity for Smad2/3 activation in the maintenance of pluipotency in 
cultured blastocyst outgrowths versus mESCs, it is possible that one or both of these 
paradigms of "sternness" may not recapitulate the behavior of I C M derivatives in vivo. 
Indeed, this contradiction raises questions as to whether ES cells in culture are an 
adequate tool for the study of embryonic development. 
We have previously demonstrated the ability of BIO to maintain pluripotency of 
m E S C s and hESCs (Sato et al, 2004) and our results describing the character of Smadl/5 
and Smad2/3 activation in hESCs extend these findings to implicate a combinatorial role 
for the T G F P and Wnt signal transduction pathways in the molecular events underlying 
the undifferentiated state. In other model organisms, namely Xenopus and Zebrafish, Wnt 
and T G F p signaling are believed to converge on the induction of primary cell types 
(Figure 12). In Xenopus embryos, for example, the establishment of the organizer has 
been shown to result from the dorsally localized coincidence of three events: stabilization 
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Figure 12. Model for the formation of Spemann's Organizer by interaction of p-Catenin 
and TGFp proteins.(A) At late blastula stages, Vg1 and VegT are found in the vegetal hemi-
sphere, while P-Catenin is located in the dorsal region. (B) p-Catenin acts synergistically with 
Vg1 and VegT to activate the Xenopus Nodal-related (Xnr) genes.This creates a gradient of 
Xnr proteins across the endoderm, highest in the dorsal region. (C) High concentrations of 
Xnrs at the dorsal marginal zone (DMZ) result in the establishment of dorsal mesoderm and 
expression of inhibitors including chordin, noggin and follistatin that block the action of BMP. 
In the regions of chordin and noggin expression, BMPs are totally prevented from binding 
and these tissues become Spemann's Organizer. 
(Adapted from Scialli, Developmental Biology,6th Edition, 2001) 
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of P-catenin; Smad2/3 activation by Xnr proteins; and inhibition of Smadl/5 activation 
by the B M P inhibitors chordin, noggin and cerberus (Scialli, 2003). Input from both 
Smad2/3 and Wnt signaling has been shown to be required for the expression of the B M P 
inhibitory organizer genes (Xanthos et al, 2002). Undifferentiated hESCs exhibit the 
same reciprocal character with respect to Smad activation shown here, with Smad2/3 
signaling being active and Smadl/5 signaling being inhibited. In light of BIO's ability to 
maintain the undifferentiated state of hESCs and the dependence of this ability on active 
Smad2/3 signaling, it is tempting to speculate that the molecular basis of pluripotent 
hESC identity may be rooted in a conserved mechanism of primary cell fate specification 
evident in lower vertebrates. 
Embryonic stem cells are defined by their ability to self renew indefinitely and 
give rise to all cell types of the embryo, yet they are present for a relatively narrow 
window of the mammalian life cycle. Maintenance of pluripotency in cultured hESCs 
results from the integration of multiple signaling inputs to retain this identity through 
indefinite passages. In demonstrating a requirement for T G F p signaling, w e have defined 
one of the necessary inputs for the maintenance of pluripotency of hESCs. However, the 
means by which Smad2/3 activation has its effect are unclear. It remains to be seen what 
targets of Smad2/3 activation are involved in mediating the maintenance of the 
undifferentiated state; and the manner in which Wnt signaling and Smad2/3 activation 
collaborate to mediate pluripotency, if at all. 
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C H A P T E R 2 
Characterization of a New Human Embryonic Stem Cell Line 
Summary 
Data on gene expression profiles and optimal culture conditions for human 
embryonic stem cells are limited, indicating a need for analysis of newly and 
independently derived cell lines. W e have derived a new hESC line, RUES1, and have 
here characterized its marker expression, functional characteristics and gene expression 
profiles. W e find that RUES1 shares marker expression and functional characteristics 
with other lines. Additionally, we have also compared RT-PCR data generated from 
RUES1 to a list of marker genes shown previously by microarray analysis to be 
consistently enriched in hESCs. While RUES1 shares a marker expression profile with 
other cell lines overall, we also find differences in the expression levels among gene 
subclasses. Genes related to nuclear functions were most similar, regardless of culture 
conditions, while those related to metabolic and cell cycle function were least similar 
when compared with data sets from previous studies. W e also find that genes with 
unknown functions show very high correlations, suggesting that these genes may play 
prominent roles in sternness and are fertile ground for future exploration. Finally, we 
show that signaling related genes maintain similar levels of expression when compared to 
other cell lines, but only when analyzed under similar culture conditions. 
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Introduction 
Embryonic stem cells are a population of cells derived from blastocyst stage 
mammalian embryos that can be maintained for indefinite passages in tissue culture. In 
addition to their capacity for perpetual self-renewal, these cells are unique among 
cultured mammalian cell lines in that they have the ability to differentiate into all adult 
cell types as routinely assayed in vitro in embryoid bodies and in vivo in teratomas. The 
initial derivation (Thomson et al, 1998), and the growing number of reports (reviewed in 
Hoffman and Carpenter, 2005) on the derivation of new human embryonic stem cell lines 
(hESCs) has generated great enthusiasm for the promise they provide for cell-based 
therapies and regenerative medicine. 
Several barriers currently limit the migration of hESCs from cell culture to the 
clinic. Foremost is the common method of hESC derivation and maintainance, whereby 
the human inner cell mass (ICM) is isolated and cultured in the presence of xeno-derived 
cells and/or proteins. These methods raise the prospect of disease transfer across species 
and therefore preclude the use of most existing hESC lines in the clinic. For this reason, 
many efforts are being made to derive new hESC lines in conditions that are completely 
free from non-human influences and progress has been made toward this end (Xu et al., 
2005; Ludwig et al., 2006). To limit the variability introduced by co-culture techniques, 
many recent efforts have been focused on establishing chemically defined culture media 
that are able to maintain the undifferentiated state of hESCs. For example, an input from 
the Wnt pathway on hESC pluripotency by the G S K 3 P inhibitor, BIO, has recently been 
described to maintain the undifferentiated state for limited passages in the absence of 
MEF-conditioned medium (Sato et al, 2004). And a high concentration of basic FGF, 
acting through B M P inhibition, has been shown to be sufficient for maintenance of hESC 
pluripotency in the absence of MEF-conditioned medium (Xu et al, 2005); an activity that 
is also sufficient in completely human derived conditions (Ludwig et al, 2006). Yet 
hESCs are still most commonly cultured on M E F s or in the presence of MEF-conditioned 
medium, and alternative culture methods must be further scrutinized to ensure their 
reliability. 
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While most hESC lines share marker expression and differentiation potential, 
subtle differences have even been demonstrated between independently derived hESC 
lines. For example, culture conditions that use serum instead of serum-free conditions 
have been shown to lead to altered gene expression patterns in a single hESC line 
(Skottman et al., 2005). However, genetic differences can also lead to gene expression 
differences between lines even when maintained under common culture conditions 
(Abeyta et al., 2004; Skottman et al., 2005). A recent report reanalyzing the raw data 
from several published microarray studies of hESCs has defined a common set of 
enriched genes that traverse several commonly used cell lines cultured under different 
conditions (Suarez-Farinas et al., 2005). Yet, as these studies were limited to a small 
number of cell lines, there is still a great need to identify markers that consistently 
identify the undifferentiated state in a variety of unique cell lines cultured under different 
conditions. 
In order for them to realize their full potential, protocols for the maintenance of 
hESCs must be standardized so that consistent and predictable results can be obtained for 
their clinical or scientific use. Toward this end, we report the derivation and 
characterization of a new hESC line, R U E S 1 , and evaluate its molecular phenotype 
relative to data from existing hESC lines. W e isolated the ICMs from frozen-thawed 
blastocysts that were obtained with informed consent and in excess of clinical need, and 
derived an embryonic stem cell line that showed the classic hESC phenotype under 
commonly used culture conditions. W e subjected this new line to rigorous molecular 
analysis to confirm the phenotype, demonstrated formation of embryoid bodies and 
teratomas containing derivatives of all three primary germ layers, and compared the 
expression profile of genes known to be consistently enriched in hESCs (Suarez-Farinas 
et al., 2005) between our new line and existing lines. This work highlights one set of 
molecular markers that can be used to consistently identify the similarities in the 
undifferentiated phenotype of hESCs maintained under standard conditions and another 
set that are sensitive to culture differences. 
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Results 
Derivation of RUES1 
We isolated an hESC line on mouse embryonic fibroblasts by immunosurgery 
from 10 thawed blastocysts that had been frozen at day six of in vitro development after 
in vitro fertilization (Thomson et al., 1998; Cowan et al., 2004). Although the number of 
attempts was low, the ability to derive lines appeared to correlate with the quality of the 
thawed blastocyst. Following the grading system developed by the Cornell University 
program (Veeck, 2003), 4(40%) of the blastocysts were deemed to be of grade 2BB or 
higher with a distinguishable ICM composed of tighly packed cells (Figure 13A). The 
remaining blastocysts lacked a distinguishable ICM and appeared to have fewer cells 
overall with incomplete blastocoel expansion indicating delayed development or poor 
health. Of the four good quality blastocysts, three resulted in a primary outgrowth (Figure 
13B and C). One of these outgrowths expanded with continued culture and gave rise to 
colonies with tightly packed cells with a high nuclear to cytoplasm ratio (Figure 13D). 
These could be maintained on MEFs (Figure 13E) by manual dissection (Mitalipova et 
al., 2005; Oh et al., 2005) or transferred to and maintained on Matrigel coated plates 
(Figure 13F) in M E F conditioned medium (Hoffman and Carpenter, 2005) for more than 
30 passages. This line was named RUES1. Karyotype analysis revealed that the line is 
male [46, XY] and most cells had a normal karyotype (26/30) after 6 passages (Figure 
13G). The infrequent abnormal karyotypes included trisomies of chromosomes 7, 17, and 
19. However, as other chromosomes were lost and we did not find multiple cells with 
these three trisomies, we believe this may represent random instabilities in this culture. 
Time lapse video-microscopy established that the RUES1 cell cycle is about 30 hours 
(data not shown). This is equivalent to the rate of most hESCs, reported to be about 24 to 
36 hours, with a range of 12 hours to 72 hours (Cowan et al. 2004). 
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Figure 13. Derivation and marker expression of RUES1. RUES1 
was derived from a 6 day old blastocyst (A).The ICM isolated by 
immunosurgery is shown (B). This ICM attached to the MEF feeder 
layer an produced a primary outgrowth (C). A colony of small ICM-
like cells with a high nuclear to cytoplasmic ratio resulting from 
an outgrowth from the inner cell mass of this embryo is shown at 
passage 1 (D) and passage 3 (E).Some colonies were transferred 
at passage 3 to Matrigel-coated plates in MEF conditioned medium 
and imaged at passage 9 (F). An example of a normal karyotype is 
shown (G). 
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RUES1 marker expression 
We next examined the expression of markers of pluripotency in culture when 
RUES1 was grown either on MEFs or on Matrigel using culture medium conditioned by 
MEFs (Figure 14). Under these conditions, RUES1 expressed previously described 
molecular markers of pluripotency (Hoffman and Carpenter, 2005). The markers Oct-3/4 
(POU5F1, Figure 14A and D), SSEA4 (Figure 14B and E), TRA-1-60 (Figure 14C), and 
alkaline phosphatase (Figure 14F) were readily detected. By real-time RT-PCR, 
expression of Oct-3/4, Nanog, and Cripto-1 (Figure 14G) were also detected. These data 
demonstrate that RUES1 is similar to previously reported cell lines in origin, growth 
properties, and marker expression. 
Differentiation potential of RUES1 
A common method used to assay differentiation potential of hESCs involves 
culture of hESC aggregates in suspension. By this method, embryoid bodies are formed 
in which hESC derivatives with molecular identities representative of all three primary 
germ layers are contained. RUES1 was able to form complex and cystic embryoid bodies 
when aggregated and cultured in suspension in vitro (Figure 15A). Embryoid bodies 
could be maintained in suspension culture for at least 5 months and during this period, 
beating cardiac myocytes were observed, indicating the presence of functional mesoderm 
differentiation (arrow in Figure 15B). After prolonged in vitro culture and reattachment 
to adhesive substrates, embryoid bodies generated multiple cell types indicative of the 
three embryonic germ layers (Figure 15C-F). Neural cell types were evident in 
outgrowths from the EBs (data not shown). Immunostaining for Nestin and 
Neurofilament Heavy Chain (NFH) confirmed the presence of ectoderm in these cultures 
(Figure 15C); staining for Desmin indicated the presence of mesoderm (Figure 15D); and 
staining for HNF3P demonstrated the presence of endoderm derivatives (Figure 15E). W e 
also found an early marker of trophectoderm, Cdx2, in EB cultures (Figure 15F). These 
data indicate that markers of germ layer derivatives can be induced in vitro. 
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Figure 14. Pluripotent Marker Expression in RUES1. Colonies on MEFs (A, B, C, F) and 
o n Matrigel (D,E) were analyzed for the pluripotency markers Oct-3/4 (A,D),SSEA4 (B,E), 
TRA-1-60 (C) by immunofluoresence. Colonies o n M E F s were also positive for Alkaline 
phosphatase (F) by cytochemistry. Pan nuclear counterstain is s h o w n in green; markers 
are s h o w n in red.(G) Real-time RT-PCR analysis of pluripotency markers. S h o w n are 
amplification plots of relative fluorescence vs. cycle n u m b e r for Oct-3/4, Nanog, and 
Cripto-1. p2-microglobulin as an amplification control. T h e no-RT controls are indicated 
for each primer. Red lines indicate the threshold cycle of amplification used to determine 
the level of expression. Note that the no-RT controls s h o w low background amplification 
at the threshold cycle. Scale bars are 5 0 p m . 
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Figure 1 5 
Figure 15. Figure 3. Germ layer differentiation of RUES1 hESCs in embryoid bodies. 
RUES1 hESCs generate complex aggregates after 14 days of in vitro differentiation in 
suspension(A).These subsequently formed complex embryoid bodies during 2 months 
of culture (B). The arrow in B indicates an area of contracting cardiac muscle after 2 
months of culture, indicating mesoderm differentiation. When plated on adhesive sub-
strates, the EBs generated multiple differentiated cell types, including neural tissue (C). 
The neural cell types can be propagated in vitro and stain for markers of Ecotderm: nestin 
(C, blue) and Neurofilament Heavy Chain (C, red). Mesoderm, marked by Desmin (D, red), 
and Endoderm, marked by HNF3P (E, red) as well as Trophectoderm, marked by Cdx2 
(E, red), can also be found in EBs. All nuclei are shown in green. 
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Another functional quality of hESCs is their ability to form teratomas, or 
disorganized masses of varied differentiated cell types, when injected intramuscularly 
into immuno-compromised mice. To further demonstrate the differentiation potential of 
R U E S 1 w e generated teratomas in SCID-beige mice and analyzed them for tissue 
derivatives of the three embryonic germ layers (Figure 16). Several teratomas were 
analyzed including a single teratoma from which w e could identify neural tissue and 
retinal pigmented epithelium, representing ectoderm (Figure 16A and B) , bone, cartilage 
and squamous epithelium (Figure 16C, D and E), representing mesoderm and glandular 
tissue (Figure 16F), representing endoderm. W e used immunofluorescent staining for 
germ layer markers on another teratoma to verify these results. W e identified areas of 
neuroepithelium that stained positively for Nestin, N F H , and TuJl (Figure 16G-I); 
mesodermal tissue that stained positively for Desmin and Muscle M H C (Figure 16J and 
K ) ; and endoderm tissue that stained positively for A F P and H N F 3 P (Figure 16L and M ) ; 
w e also identified trophectoderm, as marked by Cdx2 (Figure 16N). Taken together, the 
results presented above establish that R U E S 1 is a bonafide hESC line meeting the current 
criteria of prolonged undifferentiated proliferation while maintaining the ability to 
differentiate into trophectoderm and germ layer derivatives. 
Comparison of marker gene expression 
We have recently reported the identification of a set of genes that are consistently 
enriched in undifferentiated hESCs across several independent microarray studies 
(Suarez-Farinas et al., 2005). W e verified for enrichment of 91 of these markers in 
R U E S 1 hESCs by real-time RT-PCR. R U E S 1 hESCs maintained undifferentiated on 
Matrigel in M E F conditioned medium were compared to those maintained under adherent 
conditions in non-conditioned medium for 24 days to assay differentiation ability. Table 
1 shows the fold-enrichment of these markers in undifferentiated R U E S 1 hESCs. W e find 
that 88/91 (97%) of these genes were significantly enriched in undifferentiated R U E S 1 
hESCs, of which 83 genes (94%) were enriched by 0.5 (log2 scale) or better and 49 
(56%) were enriched by more than 2-fold by RT-PCR. SERPINB9, a proteinase inhibitor, 
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Figure 1 6 
Figure 16. Germ layer differentiation of RUES1 hESCs in teratomas. RUES1 hESCs 
at passage 11 were also injected intramuscularly into SCID/beige mice and allowed to 
develop for 6 weeks to generate teratomas. (A-F) Histopathology of RUES1 teratoma. 
Examples of tissues from three germ layers are shown. Ectoderm: neural tissue (A) and 
retinal pigmented empithelium (B), Mesoderm: bone (C) and cartilage (D) and squamous 
epithelium (E). Endoderm: glandular tissue (F). Germ layer markers were verified by 
immunofluoresence on cryosections of the teratoma (G-N). Examples of Ectoderm (Nestin 
(G, red),Tuj1 (H,red) and NFH (I, red)), Mesoderm (Desmin (J, red) and Muscle M H C (K, red)), 
and Endoderm (AFP (L, red) and HNF3P (M, red)) are shown. In addition,Trophectoderm 
(Cdx2 (N, red)) is present. (All nuclei are shown in green. Scale bars in G-N - 50 uM.) 
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Table 1. Real-time RT-PCR analysis of genes consistently enriched in undifferentiated 
hESCs. 
Symbol Description UniGene FCH* p value 
Signaling factors 
EBAF 
STC1 
PROM1 
FZD5 
CRABP1 
TRIP 
TRIP8 
SLC16A1 
SEMA6A 
SIRT1 
THY28 
CXADR 
HOMER1 
BCOR 
FABP5 
HMGB3 
RAB3B 
PODXL 
CD24 
ACVR2B 
GULP1 
KCNN2 
BMPR1A 
PELI1 
Nuclear factors 
PIM2 pim-2 oncogene 
POU5F1 POU domain, class 5, transcription factor 1 
ZNF74 zinc finger protein 74 
PSIP1 PC4 and SFRS1 interacting protein 1 
SNRPF small nuclear ribonucleoprotein polypeptide F 
ADPRT ADP-ribosyltransferase (NAD+; poly (ADP-ribose) 
polymerase) 
SOX2 SRY (sex determining region Y)-box 2 
M96 metal response element binding transcription factor 2 
RNF138 ring finger protein 138 
SNRPD2 small nuclear ribonucleoprotein D2 polypeptide 
16.5kDa 
ZNF43 zinc finger protein 43 
RBMX RNA binding motif protein, X-linked 
SMC6L1 SMC6 structural maintenance of chromosomes 6-like 1 
HNRPC heterogeneous nuclear ribonucleoprotein C (C1/C2) 
LSM3 LSM3 homolog, U6 small nuclear RNA associated 
JADE1 PHD protein Jade-1 
TCERG1 transcription elongation regulator 1 (CA150) 
NASP nuclear autoantigenic sperm protein 
ZNF198 zinc finger protein 198 
DATF1 death associated transcription factor 1 
CPSF6 cleavage and polyadenylation specific factor 6, 68kDa 
endometrial bleeding associated factor (Lefty A) 
stanniocalcin 1 
prominin 1 
frizzled homolog 5 
cellular retinoic acid binding protein 1 
TRAF interacting protein 
thyroid hormone receptor interactor 8 
Solute carrier family 16 member 1 
semaphorin 6A 
Sirtuin 1 
thymocyte protein thy28 
coxsackie virus and adenovirus receptor 
Homer homolog 1 
BCL6 co-repressor 
fatty acid binding protein 5 
high-mobility group box 3 
RAB3B, member RAS oncogene family 
podocalyxin-like 
CD24 antigen 
Activin A receptor, type MB 
GULP, engulfment adaptor PTB domain containing 1 
potassium intermediate/small conductance calcium-
activated channel, subfamily N, member 2 
bone morphogenetic protein receptor, type IA 
Pellino homolog 1 
Hs.25195 
Hs.25590 
Hs. 370052 
Hs. 152251 
Hs.346950 
Hs.21254 
Hs.442675 
Hs.75231 
Hs.443012 
Hs.31176 
Hs. 13645 
Hs.79187 
Hs.129051 
Hs. 186424 
Hs.408061 
Hs.19114 
Hs. 123072 
Hs. 16426 
Hs.375108 
Hs.23994 
Hs. 107056 
Hs.98280 
Hs.2534 
Hs.7886 
Hs.80205 
Hs.249184 
Hs. 127476 
Hs.351305 
Hs. 105465 
Hs. 177766 
Hs.816 
Hs.31016 
Hs. 180403 
Hs.424327 
Hs.419763 
Hs.380118 
Hs.424559 
Hs.476302 
Hs.111632 
Hs. 12420 
Hs.300052 
Hs.446206 
Hs.315241 
Hs.438300 
Hs.64542 
38.19 
5.48 
4.77 
4.13 
3.76 
3.11 
2.94 
2.88 
2.85 
2.62 
2.59 
2.42 
2.24 
1.97 
1.86 
1.80 
1.78 
1.60 
1.58 
1.51 
1.46 
1.36 
1.24 
1.08 
6.34 
4.71 
3.29 
2.39 
2.39 
2.34 
2.27 
2.24 
2.06 
2.05 
1.98 
1.98 
1.90 
1.75 
1.71 
1.64 
1.63 
1.60 
1.50 
1.44 
1.32 
3.22E-05 
1.26E-04 
1.69E-05 
1.56E-06 
1.14E-05 
8.06E-07 
1.16E-04 
2.58E-06 
1.61E-04 
3.55E-04 
2.34E-04 
2.37E-04 
2.45E-03 
8.25E-04 
3.77E-05 
4.52E-05 
3.22E-02 
1.02E-03 
243E-04 
1.76E-02 
4.16E-05 
1.86E-02 
3.75E-02 
3.54E-01 
2.25E-06 
1.27E-04 
3.61 E-06 
4.43E-05 
1.34E-04 
8.92E-04 
1.04E-04 
6.44E-05 
6.22 E-04 
8.63E-04 
3.31 E-05 
1.05E-03 
1.87E-04 
5.55E-03 
6.62E-04 
3.94E-04 
4.62E-03 
3.37E-03 
2.19E-02 
5.78E-04 
1.17E-03 
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Metabolic, structural and cell cycle related factors 
UCHL1 ubiquitin carboxyl-terminal esterase L1 (ubiquitin 
thiolesterase) 
UBE2C ubiquitin-conjugating enzyme E2C 
DNAJB5 DnaJ (Hsp40) homolog, subfamily B, member 5 
PRPS1 phosphoribosyl pyrophosphate synthetase 1 
PSMD11 proteasome (prosome, macropain) 26S subunit, non-
ATPase, 11 
NUDT1 nudix (nucleoside diphosphate linked moietyX)type 
motifl 
CTH Cystathionase (cystathionine gamma-lyase) 
CA14 carbonic anhydrase XIV 
GFPT2 glutamine-fructose-6-phosphate transaminase 2 
PPAT phosphoribosyl pyrophosphate amidotransferase 
MRPL42 mitochondrial ribosomal protein L42 
UGP2 UDP-glucose pyrophosphorylase 2 
U N G uracil-DNA glycosylase 
PP591 FAD-synthetase 
DNAJB6 DnaJ (Hsp40) homolog, subfamily B, member 6 
TNP03 transportin 3 
ATP5H ATP synthase, H+ transporting, mitochondrial FO 
complex, subunit d 
GYG2 glycogenin 2 
GCNT2 glucosaminyl transferase 2, l-branching enzyme 
ASMTL acetylserotonin O-methyltransferase-like 
MRPS27 mitochondrial ribosomal protein S27 
SERPINB9 serine (or cysteine) proteinase inhibitor, clade B 
(ovalbumin), member 9 
ACTN3 actinin, alpha 3 
VDP vesicle docking protein p115 
PTTG1 pituitary tumor-transforming 1 
CKS1B CDC28 protein kinase regulatory subunit 1B 
CCND1 cyclin D1 (PRAD1 
CDC25C cell division cycle 25C 
CDC7 CDC7 cell division cycle 7 
BUB1 BUB1 budding uninhibited by benzimidazoles 1 
homolog 
Unknown factors 
FLJ12505 hypothetical protein FLJ12505 
FLJ10156 hypothetical protein FLJ10156 
FN5 FN5 protein 
C21orf45 chromosome 21 open reading frame 45 
KIAA0116 KIAA0116 protein 
DLG7 discs, large homolog 7 (Drosophila) 
CGI-30 CGI-30 protein 
FAM29A family with sequence similarity 29, member A 
KIAA0095 KIAA0095 gene product 
P15RS hypothetical protein FLJ10656 
FLJ20343 hypothetical protein FLJ20343 
BMS1L BMS1-like, ribosome assembly protein (yeast) 
C6orf111 chromosome 6 open reading frame 111 
NIF3L1 NIF3 NGG1 interacting factor 3-like 1 (S. pombe) 
FLJ20530 hypothetical protein FLJ205300530 
FLJ 11323 hypothetical protein FLJ11323 
Hs.76118 
Hs.93002 
Hs.237506 
Hs.56 
Hs.443379 
Hs.413078 
Hs. 19904 
Hs. 192491 
Hs.30332 
Hs.311625 
Hs.331202 
Hs.417361 
Hs.78853 
Hs. 118666 
Hs.181195 
Hs.412527 
Hs. 155728 
Hs.380757 
Hs.934 
Hs.458420 
Hs.376200 
Hs. 104879 
Hs.445037 
Hs.325948 
Hs.350966 
Hs.374378 
Hs.371468 
Hs.656 
Hs.28853 
Hs.287472 
Hs.96885 
Hs.404323 
Hs.416456 
Hs.49932 
Hs.254717 
Hs.77695 
Hs.440776 
Hs.54617 
Hs.295014 
Hs.300906 
Hs. 171044 
Hs. 10848 
Hs.414993 
Hs.21943 
Hs.370888 
Hs.378766 
3.77 
3.25 
2.96 
2.70 
2.63 
2.52 
2.30 
2.22 
2.21 
2.18 
2.13 
2.12 
2.06 
1.84 
1.78 
1.68 
1.66 
1.65 
1.65 
1.64 
1.58 
0.42 
3.44 
1.32 
4.94 
2.81 
2.35 
1.91 
1.49 
1.47 
3.97 
2.71 
2.67 
2.64 
2.62 
2.51 
2.27 
2.17 
2.03 
1.96 
1.80 
1.80 
1.79 
1.64 
1.50 
1.37 
1.13E-06 
4.45E-05 
1.96E-07 
244E-04 
1.15E-05 
6.75E-05 
8.95E-06 
3.41 E-05 
1.00E-04 
1.43E-04 
2.41 E-03 
2.24E-06 
1.36E-04 
7.27E-03 
1.11 E-03 
6.66E-05 
3.49E-03 
1.69E-02 
3.12E-02 
4.31 E-04 
4.49E-04 
4.64E-04 
4.73E-06 
5.09E-02 
248E-05 
3.04E-07 
6.87E-05 
2.01 E-01 
3.26E-06 
6.32E-03 
4.27E-05 
8.73E-05 
2.08E-04 
7.22E-04 
1.01E-06 
3.43E-05 
9.15E-06 
4.68E-04 
3.93E-05 
2.80E-05 
6.98E-05 
7.71 E-04 
4.06E-02 
7.15E-03 
1.10E-03 
2.54E-02 
*Fold enrichment by Real-time RT-PCR on undifferentiated RUES1 hESCs compared to differentiated 
RUES1 hESCs calculated by the Comparative Ct method. Primers sequences are available upon request. 
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was the only tested gene significantly enriched in the differentiated R U E S 1 hESCs, 
whereas it has previously been shown to be enriched in undifferentiated hESCs (Suarez-
Farinas et al., 2005). However, as reported previously, this list of genes does not 
exclusively include the most enriched genes but also those that are weakly, but 
significantly, and consistently regulated with differentiation. Therefore, w e also 
correlated the fold-enrichment (log2 scale) by real-time RT-PCR to the M-values (log2 
fold-change) for the microarray studies previously reported to determine the degree of fit 
between R U E S 1 marker expression and that of other hESC lines. As shown in Figure 17, 
the degree of fit between R U E S 1 gene expression and the mean M-values for three 
previously reported microarray studies was good with positive slopes and correlation 
coefficients (Figure 17A, blue triangles and line). The correlations were greatly improved 
when R U E S 1 is compared to the microarray study data reported by Sato et al. (Sato et al., 
2004), presumably because the culture conditions used in that study were identical to our 
own (Figure 17A, red squares and line). These data indicate that R U E S 1 hESCs are very 
similar in their gene expression to previously derived lines and this similarity is increased 
when compared to another cell line (HI) maintained under similar culture conditions. 
As the degree of fit improved when RUES1 hESCs were compared to previous 
hESC lines maintained under similar culture conditions, w e asked if any differences 
existed between functional classes of genes that could distinguish R U E S 1 hESCs from 
other cell lines. The lists of enriched genes were sorted into four functional classifications 
(presented in Table 1) and compared between R U E S 1 and the Sato study alone, or 
between R U E S 1 and the mean values for all expression studies. The mean log2 RT-PCR 
fold-change was not significantly different among the groups (by A N O V A , p=0.4368). 
The nuclear factor classification maintained the greatest degree of fit between R U E S 1 
gene expression and both the Sato study alone and the mean for the all studies (Figure 
17C). Genes categorized as Metabolic, structural and cell cycle related did not show 
significant correlation between R U E S 1 and either data set (Figure 17D). One member in 
the structural subgroup, A C T N 3 , did show similar levels of expression among 
comparisons, however, its inclusion did not affect the overall results. W h e n signaling 
related factors were compared, enriched genes and their levels of expression were only 
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Figure 17 
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Figure 17. Real-time RT-PCR analysis of consistently enriched genes. Shown are linear fits 
between real-time RT-PCR analysis and microarray data from previously published studies for 
genes significantly enriched in RUES1 HESCs by real-time RT-PCR (A-E). For all plots, the log2-
fold change by RT-PCR vs. the M-values reported in our previous study (Sato et al, 2004), which 
had identical culture conditions to this study are shown with red squares and regression lines. 
The log2-fold change by RT-PCR vs. the mean M-values reported previously (Suares-Farinas et al, 
2005) are shown with blue triangles and regression lines. (A) Fits for all significant genes com-
pared to Sato study alone (r=0.6096, p<0.0001, R2=0.3717) and mean for all microarray studies 
(r=0.3514, p=0.0008, R2=0.1235). (B) Fits for Signaling factors compared to Sato study alone 
(r=0.7919, p<0.0001, R2=0.6271) and mean for all microarray studies (r=0.3114, p=0.1481, 
R2=0.09697). (C) Fits for Nuclear factors compared to Sato study alone (r=0.0.7740, p<0.0001, 
R2=0.5990) and mean for all microarray studies (r=0.5777, p=0.0061, R2=0.3337). (D) Fits for 
Metabolic, structural and cell cycle related factors compared to Sato study alone (r=0.2033, 
p=0.2994, R2=0.04133) and mean for all microarray studies (r=-0.01186, p=0.9522, R2=0.0001407). 
(E) Fits for Unknown factors compared to Sato study alone (r=0.7522, p=0.0008, R2=0.5658) and 
mean for all microarray studies (r=0.7425, p=0.0010, R2=0.5513). 
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similar between hESC lines that were maintained under similar culture conditions (Figure 
17B). A significant degree of fit was obtained when R U E S 1 signaling related factors 
were compared to the Sato study alone but was not significant when compared to the 
mean for the previous studies. This analysis suggests that differences in cell line and/or 
culture conditions are negligible to the expression levels of enriched nuclear factors 
between hESC lines, though the expression levels of metabolic and cell cycle gene 
expression varies considerable between R U E S 1 and other cell lines. Furthermore, the 
enrichment of signaling related factors is only conserved between hESC lines maintained 
in similar culture conditions. And surprisingly, genes classified as having unknown 
functions showed good correlation in both comparisons (Figure 17E), suggesting that 
these genes might have consistent and important functions to the maintenance of 
sternness across cell line and culture conditions. Taken together, these data suggest that 
differences in culture conditions may result in the use of different signaling pathways that 
converge on common nuclear factors to maintain pluripotency. 
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Discussion 
Much remains to be understood about the basic biology of hESCs and the 
differences among hESC lines. To date, several labs have reported the derivation of over 
90 hESC lines (reviewed in Hoffman and Carpenter, 2005). These lines have been 
maintained under a variety of culture conditions and have been characterized by limited 
in vitro and in vivo functional assays. In this study, w e add to this growing list a new 
hESC line, R U E S 1 , that is capable of robust expansion and retains pluripotent 
differentiation potential. W e derived the new hESC line under commonly used conditions 
and show that it can be maintained in culture media typically used to culture hESCs. W e 
show that a list of marker genes previously found to be consistently expressed in hESCs, 
regardless of cell line or culture conditions, consistently marks this new line. These data 
suggest that R U E S 1 possesses functional and molecular similarities to other reported 
lines. However, upon examination of signaling related factors within this list, some 
variation between this line and previously published lines is evident. Further analysis of 
the diversity among hESC lines may help uncover details of their biology. 
The availability of culture conditions devoid of animal products or the need for 
co-culture will be necessary for the efficient clinical use of hESCs and recent progress 
has been made in removing these obstacles (Xu et al., 2005; Ludwig et al., 2006). T w o 
culture systems used to date have ostensibly acted through different pathways, Wnt 
activation and F G F signaling, to maintain the pluripotency of hESCs. Relatively high 
doses of F G F have been shown to be sufficient to maintain hESCs in commercial serum-
replacement medium containing bovine serum albumin (Xu et al., 2005) and in a 
commercial medium containing only human-derived or synthetic products (Li et al., 
2005). And the small molecule inhibitor of GSK3p\ BIO, when used in the commercial 
serum-replacement medium has been shown to maintain hESC pluripotency for limited 
passages in the absence of C M by activating the canonical Wnt pathway (Sato et al., 
2004). W e found that R U E S 1 behaves similarly to existing hESC lines in either of these 
conditions, maintaining Oct-3/4 expression similarly to C M . 
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Gene expression in a cell reflects its environment. In this study, metabolic, and 
cell cycle genes, while significantly enriched, showed the most variability between 
existing hESC lines. This might be expected, as metabolic and cell cycle genes are 
sensitive to day to day changes in the local culture environment. Alternatively, these 
differences could represent genetic differences. For example, while it is expressed in this 
and other (Suarez-Farinas et al., 2005) hESC lines, A C T N 3 , a highly specialized form of 
alpha-actinin and a component of the fast glycolytic fibers in skeletal muscle, is not 
expressed in a significant proportion of the human population due to genetic 
polymorphism (MacArthur and North, 2004). However, expression level differences 
might also be due to the young age or low passage number of R U E S 1 relative to the other 
cell lines. 
As most published studies rely on the use of a relatively small number of markers 
of the pluripotent state (Brivanlou et al., 2003), the possibility of heterogeneity or even 
multiple states of functional sternness among these cultures remains. Efficiently guiding 
stem cell differentiation to an endpoint of specific cell therapy will require a more 
detailed understanding of the molecular and cellular nature of the pluripotent state. 
Several recent studies have attempted to define these markers and have identified a set of 
markers, shown to be consistently enriched in undifferentiated hESCs, that are robust to 
differences in cell line and culture conditions (Suarez-Farinas et al., 2005). Additionally, 
as genetic differences between hESCs lines (Abeyta et al., 2004; Skottman et al., 2005), 
compounded by growth in different culture conditions, could mask important underlying 
heterogeneity or functional states, it will be necessary to compare marker gene expression 
across a number of lines cultured in similar conditions. Few comparisons of the 
expression of such marker genes among lines have been reported. Here w e have shown 
that different marker gene subclasses, while consistently expressed, vary in their 
expression levels between cell lines and culture conditions. Nuclear related factors were 
expressed similarly when compared to other cell lines, regardless of culture conditions, 
while signaling related markers maintained similar levels of expression only when 
compared to cell lines maintained in similar conditions. This suggests that different 
signaling pathways may converge on common nuclear factors to maintain pluripotency in 
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hESCs. Further work will be needed to establish how varied signal transduction pathways 
may be integrated by a common set of nuclear factors to mediate hESC pluripotency. 
And the correlation between enriched genes of unknown function between multiple hESC 
lines, regardless of culture conditions, provides fertile ground for the study of 
uncharacterized factors that may have a role in hESC maintenance. Our derivation of a 
new hESC line, R U E S 1 , and the future derivation and culture of additional hESC lines in 
strictly defined conditions will allow for a comparative examination of the molecular 
bases that underlie hESC pluripotency. 
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C H A P T E R 3 
Generation of Embryonic Chimeras by Engraftment of Human Embryonic Stem 
Cells into Mouse Blastocysts 
Summary 
In addition to their potential for cell based therapies in the treatment of disease 
and injury, the broad developmental capacity of human embryonic stem cells offers 
potential for studying the origins of all human cell types. To date, the emergence of 
specialized cells from hESCs has commonly been studied in tissue culture or in 
teratomas, yet these methods have stopped short of demonstrating the E S C potential 
exhibited in the mouse (mESCs), which can give rise to every cell type when combined 
with blastocysts. Due to obvious barriers precluding the use of human embryos in similar 
cell mixing experiments with hESCs, human/non-human chimeras may need to be 
generated for this purpose. Our results show that hESCs can engraft into mouse 
blastocysts, where they proliferate and differentiate in vitro and persist in mouse/human 
embryonic chimeras that implant and develop in the uterus of pseudopregnant foster 
mice. Embryonic chimeras generated in this way offer the opportunity to study the 
behavior of specialized human cell types in a non-human animal model. Our data 
demonstrate the feasibility of this approach, using mouse embryos as a surrogate for 
hESC differentiation. 
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Introduction 
Embryonic stem cells are a population of self-renewing, pluripotent cells that are 
derived from the inner cell mass of mammalian blastocyst stage embryos, and are able to 
differentiate into all the cell types of the adult (Rossant et al., 2001). In recent years, 
hESCs have generated tremendous enthusiasm for the promise they provide of both 
revolutionizing cell-based therapies and regenerative medicine, as well as providing a 
vehicle for the study of early human embryology. While clinical application of hESCs 
does not necessarily depend on their ability to mimic natural development, the capacity 
for hESCs to model human embryogenesis, either as a whole or in part, depends largely 
on the ability of these cells to faithfully parallel their cognate population in a developing 
human embryo. 
Since their discovery, hESCs have often been defined as such by their similarity 
to mESCs, and many of the efforts directed toward hESC biology have been extrapolated 
from years of research done on m E S C s (Smith, 2001). While mouse and human ESCs 
have been shown to share similarities in their fundamental biology, there is also an 
appreciation that major differences exist between ESCs derived from the two species 
(Sato et al;, 2004; James et al., 2005). These disparities underscore the necessity for an 
independent and comprehensive examination of both the fundamental biology of hESCs, 
as well as their capacity to give rise to adult cell types. 
To date, hESC differentiation has mostly been assayed by two means: Formation 
of embryoid bodies and teratomas, both of which contain representative cell types from 
all three primary germ layers (Conley et al., 2004; Przyborski, 2005). Yet while the 
timing of gene expression in differentiating mouse embryoid bodies can mirror 
embryonic gene expression (Keller et al., 1993; Leahy et al., 1999) neither m E S C s nor 
hESCs have been shown to undergo axial morphogenesis within embryoid bodies. And 
though hESCs can give rise to relatively organized tissue rudiments within teratomas 
(Przyborski, 2005), they differentiate in response to an environment that does not reflect 
the developmental context of embryogenesis. For these reasons, engraftment of hESCs 
54 
into an embryonic environment may be better suited to the study of specialized human 
cell types in a live animal model. 
Numerous studies have demonstrated the viability and developmental potency of 
human stem cells within interspecies chimeras: H u m a n mesenchymal stem cells injected 
into el 1.5 rat embryos have been shown to give rise to complex functional structures of 
the kidney (Yokoo et al., 2005); hESCs injected into an organogenesis stage chick 
embryo have been shown to proliferate and contribute to neural cell types (Goldstein et 
al., 2002); and recently, when hESCs were injected directly into the lateral ventricle of 
el4 fetal mouse brains, they were shown to give rise to functional human neurons within 
the adult mouse brain (Muotri et al., 2005). In the present study, w e use the mouse 
blastocyst as a host for engraftment of hESCs. The advantages of using the blastocyst 
stage mouse embryo as a host for engraftment of hESCs are twofold: first, like the I C M 
and mESCs, hESCs are theoretically capable of differentiating to any cell type; second, 
engraftment into mouse embryos at the blastocyst stage allows for integration at a point 
that is relatively close in developmental timing. 
As these types of experiments are currently prohibited by the material transfer 
agreements attached to the NIH-registry cell lines, none of these hESC lines could have 
been used. W e therefore isolated a new hESC line, R U E S 1 , from human blastocysts 
donated from IVF clinics (described in detail above.) Using both unmodified and 
genetically marked R U E S 1 we showed first that R U E S 1 injected into mouse blastocysts 
proliferated, intermingled and differentiated along with host cells in cultured blastocyst 
outgrowths. Strikingly, hESCs that engrafted to mouse embryos localized to their niche 
of origin, the ICM, despite a hundred million years of evolutionary distance. W h e n 
chimeric blastocysts were implanted transiently into pseudopregnant foster mice, most of 
the resultant embryos were developmentally abnormal, though R U E S 1 derivatives 
persisted in rare embryos that proceeded through gastrulation and displayed normal 
morphology at e8. This study establishes the feasibility of adapting classic embryonic 
stem cell mixing experiments for use with hESCs. These approaches can be extended to 
take advantage of the large collection of mutant mice for use as host, and genetically 
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modified and/or diseased hESCs as graft, to address both basic embryological properties 
of hESCs as well as shed light on their potential application for cell based therapies. 
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Results 
Mouse and human ESCs can combine and differentiate in mosaic embryoid bodies 
Fundamental differences in their biology notwithstanding, the functional qualities 
of mESCs and hESCs are very much the same; they are both derived from the same 
embryonic stage and have the ability to form embryoid bodies and teratomas (Smith, 
2001; Leahy et al., 1999; Przyborski, 2005). Yet, mouse and human ESCs also show 
significant differences. For example, cell cycle length and the signaling factors that 
mediate self-renewal have been shown to be different between the two cell types (Sato et 
al, 2003; 2004; James et al., 2005). The fact that hESCs are grown on top of MEFs in 
culture experiments clearly demonstrates that embryonic cell types from the two species 
can coexist. But factors secreted by MEFs are important for the maintenance of self 
renewal in hESCs, so it is possible that paracrine signaling between mouse cells and 
hESCs within embryonic chimeras could affect the differentiation process of one or both 
cell types. Before undertaking experiments to generate embryonic chimeras, we aimed to 
ensure that hESCs could survive and differentiate when combined with their mouse 
cognate cell type. To test this, RUES1 hESCs and mESCs grown on matrigel were 
dissociated by dispase and trypsin, respectively, and combined to form mosaic embryoid 
bodies (Figure 18). Equal numbers of human and mouse ES cells (n= 5000 of each cell 
type) were mixed and cultured together in suspension for seven days. Mosaic embryoid 
bodies were then immunocytochemically examined for contribution of RUES1 cells 
using an antibody that specifically recognizes a human nuclear antigen. RUES1 cells 
were detected in significant number in the mosaic embryoid bodies, though they were 
always underrepresented relative to mouse cells (data not shown). hESCs differentiated, 
along with the mESCs, into derivatives suggesting the three primary embryonic germ 
layers in mosaic embryoid bodies. Markers of ectodermal (neurofilament heavy chain and 
Sox2 in Figure 18B-D), mesodermal (Desmin in Figure 18F-H) and endodermal (HNF3P 
in Figure 18J-L) were exhibited by both human and mouse cells. Similar contribution of 
human cells to mosaic embryoid bodies and subsequent differentiation was also obtained 
when another hESC line, HUES#6 (Cowan et al., 2004) was used (data not shown). 
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Figure 1 8 
Figure 18. Mosaic embryoid bodies generated from hESCs and mESCs show differentiation 
of both cell types to derivatives of the three primary germ layers. Equal numbers of human 
(dispase-dissociated) and mouse (trypsin-dissociated) ESCs (n=5000) were mixed in suspended 
culture for 6 days and resultant EBs were assayed immunohistochemically for the presence of 
human cell nuclei (Red) and germ layer markers for ectodermal derivatives, including neurofil-
ament heavy chain (Green in B,C) and Sox2 (Blue in D);the mesoderm marker desmin (Green in 
F-H); and the endoderm marker HNF3p" (Green in J-L). A, B, E, F, I and J show whole EBs; C, D, G, H, K 
and L show single cell resolution. Scale bars - 20 um. 
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hESCs incorporate and differentiate in mouse blastocyst outgrowths 
mESCs are derived from blastocyst stage embryos, but co-culture of mouse and 
human ESCs in mosaic embryoid bodies does not necessarily indicate how hESCs might 
behave in a bona-fide embryonic environment. In order to assess the ability of hESCs to 
proliferate, integrate and differentiate in mouse embryos, w e injected e3.5 blastocysts 
with 10-15 cell clumps of R U E S 1 and cultured the embryos in vitro for six days (Figure 
19). These experiments described below were designed to minimize hESC input into host 
embryos, in accordance with policies in place at the Rockefeller University, and are also 
in line with guidelines recommended by the National Academy of Sciences 
(http://books.nap.edu/catalog/11278.html). Figure 19A and B shows the injection 
protocol. 
As RUES1 hESCs do not tolerate trypsin-passaging, two independent means of 
R U E S 1 dissociation, trypsin and micro-dissection into cell clumps, were compared for 
their ability to integrate into host blastocysts. In each case a total of 10 to 15 cells, either 
as individual cells or in clumps, were microinjected into the blastocoel cavity of a mouse 
blastocyst. W h e n trypsin dissociated cells were compared to cell clumps, micro-dissected 
colonies showed the best quality and quantity of contribution (data not shown). Other 
available cell lines have shown poor recovery from trypsin-passaging in tissue culture 
(Amit et al., 2000), and this enzymatic treatment may account for poor contribution of 
trypsin dissociated R U E S 1 hESCs to mouse blastocysts. But another cell line H U E S # 6 
(Cowan et al., 2004), which is routinely trypsin-passaged in cell culture, also showed 
poor contribution (data not shown). For this reason, the embryonic chimeras in these 
experiments were generated by injection of manually dissociated clumps. 
In order to determine whether human cells would proliferate and mix with the 
mouse host, injected blastocysts were cultured on Matrigel™ for 6 days in vitro (Figure 
19C-I). R U E S 1 derivatives persisted in 1 4 % of cultured chimeric blastocysts after 5 days 
and resultant embryonic outgrowths showed a complex and disorganized three-
dimensional structure with human cells present in significant numbers (>500 nuclei in 
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Figure 19 
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Figure 19. hESCs survive, proliferate and incorporate into cultured 
mosaic embryos. hESCs were dissociated enzymatically by trypsin or 
manually by micro-dissection and injected into the blastocoel of e3.5 
mouse embryos.The injection scheme is shown in panels A and B. hESC-
Injected embryos were cultured in vitro on matrigel coated tissue culture 
plastic (C) for 6 days. Resultant outgrowths showed complex three dimen-
sional structure and human cells were present in significant numbers (D-1). 
Panel G shows human cells near the end of mitosis; Phoso-HistoneH3, 
which is phosphorylated in the context of mitosis, is shown in green.The 
inset in panel F is magnified as a single optical slice in panels H and I, 
which show intermingling of human cells with the host. Human nuclei 
are represented in red in E -1. SytoxGreen nuclear counterstain is shown 
in blue. Scale bars - D, E, F, H and I - 50 um; G - 20 um. 
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some cases) (Figure 19D-I). R U E S 1 derivatives were predominantly concentrated in the 
suspended body of the outgrowth, while the "stalk" by which the outgrowth adhered to 
the extra cellular matrix (star in 19F) was devoid of human cells. Cells were actively 
proliferating, as evidenced by the co-localization of Phospho-HistoneH3 (Gurley et al., 
1978) and human nuclear antigen (Figure 19G). Relative to host cells, however, human 
nuclei were underrepresented in all chimeric outgrowths (Figure 19F and data not 
shown). This evidence established that hESCs could proliferate and intermingle with their 
mouse embryonic counterparts in cultured blastocyst outgrowths. 
Mouse embryonic fibroblasts have commonly been used to maintain the 
undifferentiated state of hESCs, so it is possible that the mouse embryonic 
environment may impede the differentiation of hESCs. In order to address this, w e 
examined whether human cells within the outgrowths expressed markers of the 
differentiated state. H u m a n cells derived from all three germ layers were detected 
(Figure 20E-J). Furthermore, w e concluded that all the human cells were differentiated, 
as no R U E S 1 nuclei were positive for the pluripotency marker Oct3/4. In fact, a cluster of 
Oct3/4 positive mouse cells that was retained in one outgrowth provided a valuable 
internal control for the absence of Oct3/4 in human cells (Figure 20A-D). 
Stable expression of a genetic marker in RUES1 
In order to localize RUES1 derivatives within chimeric blastocysts and cultured 
outgrowths, w e performed immunocytochemistry on our samples using an antibody 
specific for human nuclear antigen. While these methods were adequate for our purposes, 
secondary detection by immunofluorescence can result in signal artifacts that arise from 
non-specific binding of primary or secondary antibodies. To avoid this possibility in our 
subsequent experiments, w e set out to generate hESCs that stably express green 
fluorescent protein (GFP). Because methods commonly used to generate stably 
expressing m E S C s by lipofection were not as effective in hESCs (data not shown), w e 
used lentiviral transduction to stably integrate G F P into R U E S 1 (Figure 21). W e first 
transfected H E K 293 cells with a lentiviral vector containing eGFP and used the super-
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Figure 2 0 
Figure 20. hESCs differentiate into three primary germ layer derivatives within mosaic 
outgrowths. hESCs were injected into e3.5 mouse blastocysts and cultured for 6 days on 
Matrigel. Resulting outgrowths were fixed and processed immunohisto-chemically using 
antibodies specific for Oct3/4 (Green in B and D), neurofilament heavy chain (Green in F), 
desmin (Green in H) and HNF3p (Green in J). Human nuclei are represented in red and nuc-
lear counterstain in blue. Panels C and D represent a magnified view of the inset in B. Scale 
bars - A-D, I and J - 50 um; E - H - 10 pm). 
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HIV-1 LTR (del U5) 
Figure 21.eGFP transduction of RUES1 by lentivirus. (A) Schematic m a p of the pTrip-
eGFP vector (Sirven et al., 2000; Sirven et al., 2001). (B and C) show RUES1 hESCs viewed 
with DIC (panel B),and with a composite of DIC and fluorescence in RUES1 transduced 
(at 5 X 10s ifu/ml) with pTrip-eGFP vector, after two rounds of manual passaging. 
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natant from these cells to infect R U E S 1 at 5 X IO5 infectious units/ml. After manually 
selecting for regions of strong G F P expression through two passages, homogenous, GFP-
expressing R U E S 1 colonies were obtained (Figure 2IB and C). G F P expression remained 
stable in these hESCs for more than 10 passages. 
hESCs can maintain their pluripotency within the mouse ICM niche 
Because in vitro culture of blastocyst outgrowths cannot begin to recapitulate the 
dynamic process of early embryonic development in vivo, it is unclear from these 
experiments whether hESCs and mouse I C M derivatives would combine to form a 
coherent embryo. It is possible that human cells are growing ectopically in the host 
embryo and only become intermingled with mouse cells by virtue of their proximity. 
This possibility prompted us to ask whether R U E S 1 would integrate into and maintain 
the identity of the host I C M shortly after injection. In order to address this, w e repeated 
the injection protocol and examined the expression of Oct3/4 after 24 hours of culture. 
Figure 22 shows that R U E S 1 cells that incorporated generated a small niche of Oct3/4 
positive cells among their Oct3/4 mouse counterparts in the I C M (Figure 22C, D, G and 
H) . In contrast, w e consistently observed that hESCs that did not incorporate into the 
I C M were Oct3/4 negative and showed unhealthy nuclear morphology (arrow in Figure 
22C). In these settings w e never found contribution of human cells to the trophectoderm. 
H u m a n cells that integrated into host I C M maintained Oct3/4 levels and were negative 
for the trophectoderm marker Cdx2 (Figure 22F-H). From this evidence, w e concluded 
that the differentiated cells seen in the mosaic outgrowths originated from the hESCs that 
engrafted into the host ICM. 
hESCs aggregated with blastomere stage mouse embryos engraft into ICM 
A common alternative to blastocyst injection for the generation of embryonic 
chimeras entails the aggregation of ESCs with pre-compacted blastomere stage embryos 
(Zeilmaker, 1973; Nagy et al., 1993). Given the technical difficulty and physical stress 
involved in the injection of h E S C clumps into mouse blastocysts, adapting aggregation 
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Figure 2 2 
Figure 22. RUES1 hESCs integrate into host ICM and retain pluripotent identity. 
Embryonic chimeras were generated by blastocyst injection (A-H) and fixed 24 hours 
post injection for immunohistochemical analysis. (A-D) Human cells detected by anti-
human nuclear antibody (red in B-D) that integrated into the host ICM showed healthy 
nuclear morphology (blue in B and D) and maintained Oct3/4 (green in C and D). Human 
cells that did not incorporate into host ICM exhibited unhealthy, apoptotic morphology 
and did not retain Oct3/4 (arrowhead in C). (E-H) GFP expressing hESCs (green in G and 
H) were negative for the trophoectoderm marker Cdx2 (Blue in F and H) in embryonic 
chimeras generated by blastocyst injection. Nuclear counterstain is shown in blue in B 
and D. Scale bars - 50 pm. 
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protocols to suit hESCs would not only allow for an increase in the scale of chimera 
generation, but would ensure reduced trauma to engrafted hESCs. Furthermore, prior to 
compaction, mammalian embryos have yet to make the cell fate distinction between ICM, 
which gives rise to the embryo proper, and trophectoderm, which mediates invasion of 
uterine epithelium during implantation and gives rise to extraembryonic tissues. While 
m E S C s do not normally differentiate to trophectoderm lineages in vitro, hESCs have 
demonstrated this potential (Xu et al., 2002b). Hence, engraftment of hESCs into mouse 
blastomere stage embryos provides a means of testing the ability of hESCs to take on 
dual cell fates (trophectoderm vs. ICM) concomitantly with the cells of the host. To 
address these questions, w e combined dispase-dissociated R U E S 1 colonies with pre-
compaction embryos in conical bottomed wells followed by mild centrifugation 
(Schematic shown in Figure 23A). After 48 hours, an average of 3 9 % of resultant 
blastocysts contained hESCs in three independent experiments. Engrafted cells were 
localized to the I C M of a vast majority (97%) of embryonic chimeras that formed, and 
they retained the Oct3/4 positive identity of adjacent mouse cells (Figure 23B-E). As was 
the case for R U E S 1 hESCs injected into mouse blastocysts, human cells did not exhibit 
the trophectoderm marker Cdx2 in successfully aggregated embryos (Figure 23D-F). 
However, in rare cases, aggregation resulted in chimeric blastocysts in which hESCs 
were not localized to the host I C M (arrow in Figure 23B). In these chimeras, some 
human cells retained Oct3/4 expression, but surprisingly, a minority exhibited Cdx2 
expression (arrowhead in Figure 23 G) , though at a reduced level relative to host 
trophectoderm (Figure 23G-I); and upon further differentiation in outgrowths after six 
days, Cdx2-positive human cells were also evident (data not shown). From these 
observations, w e concluded that hESCs preferentially localized to host I C M in embryonic 
chimeras generated by blastocyst injection or morula aggregation, though hESCs showed 
the capacity, in some cases, for differentiation toward trophectoderm fate. 
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Figure 2 3 
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Figure 23. RUES1 hESCs engraft into blastomere stage mouse embryos, localize to 
host ICM and retain pluripotent identity. Embryonic chimeras were generated by 
aggregation (A-l) and fixed 48 hours post aggregation for immunohisto-chemical analysis. 
A schematic describing the aggregation protocol is shown in (A). (B-F) A majority of 
embryonic chimeras generated from morula aggregation showed localization of hESCs 
(green in C, E and F) to host ICM with retention of Oct3/4 (red in C-F) and absence of 
Cdx2 (blue in C, D and F). (G-l) Rare embryos contained hESC derivatives (green in H and 
I) that were positive for Cdx2 (arrowhead in G). Panels D-F and G-l show magnified views 
of embryonic chimeras indicated by the arrowhead and arrow, respectively, in panel B. 
Scale bars - 50 um. 
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hESCs persist in implanted embryonic chimeras in vivo 
Given the strikingly disparate developmental schedules for mouse and human 
embryogenesis, it is unexpected that embryonic cell types from the two species could be 
combined within chimeras to form a coherent embryo. To determine whether embryonic 
chimeras generated by blastocyst injection would give rise to developmentally viable 
embryos in vivo, w e implanted hESC-injected blastocysts into the uterus of 
pseudopregnant foster mice and retrieved them at embryonic day 8 (Figure 24). Of 28 
chimeric embryos that were implanted, 24 formed deciduae that contained embryos. 13 of 
these embryos were phenotypically normal and did not contain GFP-positive R U E S 1 
derivatives (Figure 24A, left); 7 embryos were developmentally delayed and did not 
contain R U E S 1 derivatives (Figure 24A, right); and 3 embryos contained GFP-positive 
R U E S 1 derivatives, but showed aberrant morphology (Figure 24B and C). Strikingly, one 
embryo was morphologically identical to normal littermates, but contained 10 GFP-
positive hESC derivatives localized to the prospective foregut endoderm and 
neuroepithelium (Figure 24D-H). The persistence of human cells in implanted chimeras 
was supported by a separate data set, in which human cells were shown by 
immunocytochemistry to persist in rare embryos, specifically in the anterior neural folds 
of embryonic chimeras at e8.5 (Figure 24I-K). From these experiments, w e concluded 
that hESCs can persist in embryonic chimeras implanted in vivo and furthermore, that 
they can be maintained in an embryo that proceeds normally through gastrulation. 
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Figure 2 4 
Figure 24. hESC-derivatives are retained in embryonic chimeras following implantation 
in vivo. hESC-injected blastocysts were implanted into the uterus of pseudopregnant foster 
mice and recovered after 5 days of development. (A) Examples of implanted blastocysts that 
resulted in wild type phenotype (left) and aberrant/delayed phenotype without GFP-positive 
hESC contribution (right). (B and C) Brightfield and fluorescent images of abnormal embryos 
containing GFP-positive hESC contribution. (D-H) Morphologically normal embryo containing 
10 GFP-positive hESC derivatives. (D) saggital view; (E-H) anterior view. (I-K) A section of the 
neural fold region of an embryonic chimera at e8.5 was labeled by immunocytochemistry 
with the anti-human nuclear antigen antibody. Multiple positive human nuclei are shown. 
Nuclear counterstain is shown in red in (F) and (H) and in blue in (J and K); GFP-positive cells 
are shown in green in (C,G and H); cells that were positive for the anti-human nuclear stain 
are shown in red in (I and K). Scale bars -100 um. 
69 
Discussion 
Embryonic cell mixing and recombination experiments between closely related 
species is a traditional approach of experimental embryology, used for more than a 
hundred years to understand embryonic processes at the cellular level. The origin of these 
methods can be traced to experiments in which early embryonic explants were 
transplanted between frog and newt gastrulae; an approach that allowed the identification 
of the origins of inductive signals during embryogenesis (Spemann, 1918; Spemann, 
1921; Spemann and Mangold, 1923). Later work demonstrated that when presumptive 
jaw epithelium of a 5 day old chick embryo is recombined with the molar mesenchyme of 
an el6 mouse molar mesenchyme, a "hen's tooth" is generated (Kollar and Fisher, 1980). 
This established that the cells of the chick, which have not made teeth for nearly 100 
million years, are still competent to respond to an appropriate inducer. In the past few 
decades, these and other pioneering experiments have contributed greatly to the 
understanding of vertebrate embryogenesis, but relative to other model species, a similar 
understanding of our own development has been elusive. hESCs have the potential to 
resolve this. In this study, w e chose to test the capacity of a new hESC line, R U E S 1 , to 
incorporate into the closely related embryonic environment of the mouse ICM. W e 
showed that hESCs engrafted into pre-implantation stage mouse embryos and proliferated 
into differentiated human derivatives in the context of host tissue in vitro. In addition, w e 
showed that there is biological compatibility between both human and mouse cells in the 
I C M of mouse blastocysts as well as following implantation into pseudopregnant foster 
mice. These data establish for the first time that hESCs can integrate into the mouse 
embryo, validating the potential for non-human embryos to serve as a surrogate 
environment in which to study hESCs and their derivatives. 
Our study complements previous evidence establishing that ESCs have the 
capacity to integrate into extra-species hosts; m E S C s differentiated in vitro to motor 
neurons innervate chick hind legs (Wichterle et al., 2002); and hESCs differentiate into 
neuronal cell types in ovo in the context of the chick embryo (Goldstein et al., 2002) or 
when injected directly into lateral ventricles of el4 fetal mouse brains (Muotri et al., 
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2005). While these studies recombine late stage or stage-mismatched tissue, our 
embryonic chimeras are recombined from cells of the same stage as the one from which 
they were derived: the blastocyst. Twenty four hours after injection into mouse 
blastocysts, hESCs that were not incorporated into the I C M showed fragmented nuclear 
morphology suggestive of apoptosis or necrosis. And those hESCs that did incorporate 
into I C M maintained Oct3/4 expression at levels similar to adjacent mouse cells, while 
those that did not incorporate were negative for Oct3/4. Embryonic chimeras were also 
generated by aggregation of hESCs with blastomere stage embryos, and 48 hours after 
aggregation, hESCs were again localized to the host I C M and maintained Oct3/4 levels 
similar to adjacent host cells. 
Localization of hESCs to host ICM is relevant to the ability of embryonic 
chimeras to implant and develop in vivo. Chimeras generated from aggregation of rat and 
mouse embryos show varied developmental progress depending on the methods used to 
combine them. W h e n rat and mouse embryos are combined at the blastomere stage, rat 
cells contribute to the trophectoderm of the chimeras and they fail to implant into mouse 
uterus, presumably due to an immune response against the foreign rat component 
(Rossant, 1976). However, when rat I C M cells are injected into blastocyst stage mouse 
embryos, they do not contribute to trophectoderm, and these chimeras are able to implant 
and develop as far as early organogenesis stages (Gardner and Johnson, 1973; Gardner 
and Johnson, 1975). Our observation that injected hESCs almost always engraft into host 
I C M and do not contribute to host trophectoderm, regardless of their being derived by 
blastocyst injection or morula aggregation, suggests that chimeras generated by either 
method should at least be able to implant into the uterus of mouse foster mothers. Indeed, 
embryonic chimeras generated by blastocyst injection were able to implant and develop 
within foster mice, though the influence of hESCs seemed to disrupt embryogenesis in 
most cases. 
The generation of interspecific chimeras using mouse pre-implantation embryos 
was first accomplished in 1973, when chimeric blastocysts were generated from mouse 
and rat embryos (Mulnard, 1973; Stern, 1973; Zeilmaker, 1973). Since then, embryonic 
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chimeras have been generated from combinations of mouse and vole (Mystkowska, 
1975), the variant mouse species M u s musculus and M u s caroli (Rossant and Frels, 
1980), the variant cow species Bos taurus and Bos indicus (Williams et al., 1990), and 
sheep and goat (Fehilly et al., 1984). Not surprisingly, chimeras generated from the more 
evolutionarily distant species were not viable, presumably due to irreconcilable 
differences between developmental programs - chimeras between mouse and vole or 
mouse and rat, for instance, did not come to term and only rarely developed to advanced 
stages in utero. O n the other hand, chimeras generated from mixing embryos of closely 
related species (Mus musculus and M u s caroli, Bos taurus and Bos indicus, or sheep and 
goat) resulted in successful development to adulthood. Considering these results, it seems 
unlikely that chimeras generated from engraftment of hESCs into mouse blastocysts 
would develop into viable chimeric embryos. Our results show the majority of embryonic 
chimeras that implanted and retained hESC derivatives were developmentally 
abnormal/delayed. But rarely, hESCs persisted in morphologically normal embryos, 
demonstrating that hESC engraftment is not irreconcilable with mouse embryogenesis. In 
fact, the differences between mouse and human embryogenesis may account for these 
rare morphologically normal embryos. In particular, the difference in cell cycle between 
mouse and human ESCs may explain the relative scarcity of hESC derivatives in our 
embryonic chimeras at e8: Considering our experimental design, in which hESC 
contribution was intentionally minimized, combined with the relatively slow pace of 
hESC proliferation and/or human embryogenesis, it makes sense that hESC derivatives 
should be underrepresented; and if human contribution is minimized, the relatively brisk 
pace of mouse development may allow the host cells to out-compete the hESC 
derivatives, resulting in "pockets" of human cells in a morphologically normal mouse 
embryo. 
The observation that RUES 1 localized to the ICM of host blastocysts indicated 
that hESCs preferentially occupied a niche that parallels that of their origin, the ICM. 
Yet, the emergence of functional neurons from undifferentiated hESCs injected directly 
into the lateral ventricles of el4 mouse brains (Muotri et al., 2005) establishes that 
pluripotent human cells and their derivatives can respond appropriately to the inductive 
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signals of an evolutionarily distant niche. In our embryonic chimeras that were generated 
by aggregation of hESCs with blastomere stage mouse embryos, hESCs rarely engrafted 
"ectopically" into regions of trophectoderm upon blastocyst formation (Figure 23N-P). In 
these embryos, most of the hESC derivatives retained Oct3/4 expression, but in a subset 
of the engrafted cells, Oct3/4 was completely lost, and a weak Cdx2 signal was observed. 
While little can be concluded as to the timing of differentiation in mouse vs. human cells 
from these experiments, they did provide some indication that human cells were capable 
of taking on the molecular identity of the niche into which they engrafted. Following 
from our work, it is feasible that mouse/human chimeras could be generated in which 
hESCs are engrafted into pre-implantation stage mouse embryos and distributed 
throughout the host anatomy through gastrulation. This may allow for chimeras in which 
hESC derivatives are "seeded" into an array of developmental niches within a viable 
mouse, which would be of considerable value for the modeling of human development 
and disease in live animals. 
While these experiments are in line with ethical guidelines set forth by the 
National Academy of Sciences (http://books.nap.edu/catalog/11278.html), w e 
purposefully restricted our analysis to early developmental stages and minimized hESC 
engraftment in order to affirm the feasibility of these assays. A s such, the current study is 
lacking in some respects. First, in order to further explore the utility of embryonic 
chimeras as a vehicle for examining the emergence and behavior of human cell types, w e 
must characterize the extent to which human cells can contribute to a viable mouse-
human chimera. Allowing progression of chimeras to later developmental time points 
would indicate whether hESC derivatives are capable of integrating functionally into host 
anatomy. Second, in the rare instances in which hESC derivatives persisted in 
morphologically normal chimeras, the observed GFP-positive cells could have been a 
result of cell fusion rather than persistence of bona-fide human cells. Given the rarity of 
this phenotype and the scarcity of presumed human cells, it is difficult to rule out the 
possibility of cell fusion without increasing the scale of the experiments and allowing 
further proliferation of hESC derivatives within chimeras left to develop to later stages. 
The efficiency of blastomere stage embryo aggregation with hESCs allows for a scalable 
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platform whereby embryonic chimeras can be generated in which hESC input is varied 
by number and/or differentiation state. 
Regardless of whether human cells can accommodate the spatiotemporal 
signaling environment and/or developmental schedule of mouse embryogenesis in any or 
all instances, the generation and culture of mouse/human chimeras in vitro may at least 
allow for a study of the murine embryonic explant's influence on hESC differentiation, 
yet engraftment of hESC derivatives into live chimeric animal models would be a much 
more valuable tool. Provided that hESCs can be reconciled with mouse embryogenesis in 
vivo, engrafting hESCs into host anatomy before gastrulation may provide an accessible 
platform for studying the emergence of many human cell types; and with the expansion 
of available hESCs to include genetically diseased lines, mouse/human chimeras may 
allow us to elucidate the bases of disease by examining the behavior of such hESC lines 
in live animal models. In these ways, the advances reported here provide a foundation for 
future work towards an understanding of human development and disease. 
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M A T E R I A L S A N D M E T H O D S 
Reagents 
Human Activin A, Activin RIB/ALK-4/Fc Chimera, Activin RIIB/Fc Chimera, Cripto-1 
and Bmp4 were purchased from R&D. Mouse LIF (Esgro®) was purchased from 
Chemicon International. The TGF-p1 inhibitor SB-431542 (SB) was purchased from 
Tocris. The GSK-3(3 inhibitor, 6-bromoindirubin-3'oxime (BIO) was generously 
provided by Laurent Meijer. Pronase, Demecolcine solution, and guinea pig complement 
were purchased from Sigma. Dispase, Collagenase and basic FGF were purchased from 
Invitrogen. Primary antibodies used included phospho-Smadl/5, phospho-Smad2, and 
phospho-Ser CDKs substrate (Cell Signaling); Smadl/5 (Upstate); Smad2/3 and Oct3/4 
(Signal Transduction Laboratories); hNanog (R&D); SSEA4, Tra-1-60 and Nestin 
(Chemicon); p-tubulinlll/Tuj 1 and a-Tubulin (Sigma); Alpha-1-Fetoprotein and Human 
Placental Alkaline Phosphatase (DAKO); HNF3b, Sox2, Oct3/4 (Santa Cruz); 
MuscleMHC/MF20 (Developmental Studies Hybridoma Bank); Neurofilament Heavy 
Chain, PhosphoHistoneH3 and Desmin (Abeam); and Cdx2 (Biogenix). Secondary 
antibodies used were donkey anti-mouse, anti-goat or anti-rabbit conjugated to 
AlexaFluor488, AlexaFluor555 and AlexaFluor647 (Molecular Probes). D N A nuclear 
counterstains used were SytoxGreen, SytoxOrange and ToPro3-iodide (Molecular 
Probes). 
RUES1 derivation and culture 
Blastocysts frozen at day 6 post fertilization were donated with informed consent from 
embryos in excess of clinical need according to institutional guidelines. Identifying 
information was removed before receipt of the vials and blastocysts were thawed by 
stepwise removal of cryoprotectant. Blastocysts were washed 2X in recovery medium 
and incubated for two hours before immunosurgery to allow for blastocoel expansion and 
morphological grading. Recovery medium consisted of 10% Plasmanate, IX non-
essential amino acids, IX essential amino acids, IX GlutaMAX in Ml6 medium 
(Specialty Medium). The blastocyst was treated with 2mg/ml pronase to remove the zona 
pellucida and then incubated in a 1:10 dilution of anti-human placental alkaline 
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phosphatase antibody (DAKO). The embryos were washed three times in recovery 
medium and incubated in a 1:10 dilution of guinea pig complement (Sigma) and 
monitored for trophectoderm lysis. Lysed trophectoderm was removed by pipetting 
through a pulled pasteur pipette and isolated ICMs were washed 2X in H U E S M medium. 
H U E S M consisted of D M E M supplemented with 2 0 % KSR, IX non-essential amino 
acids, IX essential amino acids, IX GlutaMAX and 20ng/ml bFGF (Invitrogen). Human 
LIF was added (12ng/ml) during the initial outgrowth but was excluded from subsequent 
culture. ICMs were plated on a M E F feeder layer and outgrowths were micro-dissected 
and transferred to fresh feeder layers for three passages for expansion. Stable culture of 
RUES1 was maintained as previously described (Thomson et al., 1998; Xu et al., 2005). 
Cell Culture 
hESC line HI was obtained from WiCell research institute and BGN1 and B G N 2 lines 
were obtained from BresaGen. Human embryonic stem cells were maintained as 
previously described (Sato et al., 2003). B G N 2 Cells were plated on matrigel coated 
poly-D lysine/laminin Biocoat® coverslips (Becton-Dickinson) and cultured 5 days in the 
described conditions before fixation and immunofluorescence. RUES1 derivation and 
culture conditions are described above. mESCs were cultured in 15% fetal calf serum and 
maintained undifferentiated by addition of LIF to culture medium. Mitotically inactivated 
mouse embryonic fibroblasts were purchased from Specialty Media. 
Immunofluorescence 
Following culture, hESCs, mouse preimplantation embryos, mosaic embryoid bodies, 
RUES1 embryoid body and teratoma sections, mouse/human embryonic chimeras and 
mouse/human blastocyst outgrowths were fixed in 4 % Paraformaldehyde in PBS, washed 
in PBS + 0.2%o bovine serum albumin (BSA), permeabilized with 0.1% Triton X-100 in 
PBS/BSA for 20 minutes, and then blocked in 5 % donkey serum in PBS/BSA for 2 hours 
at room temperature. Cells were incubated overnight at 4°C in appropriate dilutions of 
primary antibodies. After 3 washes in PBS/BSA, cells were incubated with combinations 
of AlexaFluor488, AlexaFluor555 or AlexaFluor647 conjugated secondary antibodies for 
2 hours at room temperature. Cells were then washed with PBS/BSA and stained with 
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either 25 n M SytoxGreen, SytoxOrange or ToPro3-iodide nucleic acid stain in PBS/BSA. 
Endogenous Alkaline Phosphatase was assayed in RUES1 following the manufacturer's 
instructions (Vector Labs). Coverslips, tissue sections and/or whole tissues were mounted 
in glycerol and imaged using a Zeiss Pascal confocal microscope. 
hESC cell synchronization 
BGN1 cell cycle progression was blocked at metaphase by incubation overnight in 
conditioned medium with 100 ng/ml Demecolcine solution. Cells were washed four times 
with PBS to release them from metaphase block and then harvested for immunoblotting 
at 15 minutes and 4 hours post-release. 
Immunoblotting 
Cells were lysed with 100 ul IX lysis buffer (20 m M Tris (pH 7.5), 150 m M NaCl, 1 m M 
EDTA, I m M EGTA, 1% Triton X-100, 2.5 m M sodium pyrophosphate, 1 m M p-
Glycerophosphate, 1 m M Na3V04 and complete mini protease inhibitor cocktail (Roche). 
20 pg of total protein was loaded for each lane. Membranes were blocked in TBS with 
0.1% Tween and 5 % milk. Antibodies used were anti-phospho-Smads (Cell Signaling); 
anti-Smad2/3 (Transduction Laboratories; 1:1000); anti-Smadl (Upstate); anti-tubulin 
(Sigma); anti-Oct3/4 (Transduction Laboratories); anti-hNanog (R & D). Primary 
antibodies were incubated over night and secondary antibodies for two hours. Proteins 
were detected with ECL (Amersham Biosciences). 
RT-PCR 
Cells were lysed directly with 100 pi RNAbee (Tel-Test, Inc.) and total R N A was 
extracted. 1 pg of total R N A was reverse transcribed to cDNA and 1/20 of the RT 
reaction was used as PCR template. Radioactive amplification was according to the 
following conditions: p-actin (f: T G G C A C C A C A C C T T C T A C A A T G A G C ; r: 
G C A C A G C T T C T C C T T A A T G T C A C G C ; 21 cycles); Oct3/4 (f: G A A G G A T G T G G T -
C C G A G T G T ; r: G T G A C A G A G A C A G G G G G A A A ; 19 cycles); Nanog (f: A C C A G A A -
CTGTGTTCTCTTCCACC; r: G G T T G C T C C A G G T T G A A T T G T T C C ; 21 cycles). 
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BrdU incorporation and T U N E L assays 
The In situ Cell Proliferation, FLUOS (cat. No. 1810740) and In situ Cell Death 
Detection, Fluorescein (cat. No. 1684795) kits were obtained from Roche. B G N 2 cells 
were cultured two days in C M and then further cultured in the indicated conditions for 3 
days. Following culture, BrdU incorporation and TUNEL staining was assayed according 
to the protocols described by the manufacturer. Cells were imaged and quantified using a 
Zeiss Pascal confocal microscope. 
Blastocyst Outgrowth 
Pregnant Swiss-Webster mice were sacrificed at embryonic day 3.5 and the uterus was 
isolated and flushed with warm culture medium to obtain blastocyst stage embryos as 
described previously (Nagy, 2003). Embryos were incubated in culture medium 
containing 1 mg/ml pronase and observed continuously until the zona pellucida was 
digested. Embryos were then rinsed three times in warm culture medium and incubated 
on gelatin-coated tissue culture plastic in mouse embryonic stem cell medium (Betts et al, 
2001) containing either 20 u M SB-431542 or an equivalent dilution of D M S O . Embryos 
were not disturbed during culture in order to allow attachment and outgrowth. Embryos 
were fixed in 4 % Paraformaldehyde in PBS at 4 days post extraction and processed for 
immunofluorescence in the same manner as the hESC. RUES1 injected blastocysts and 
RUES1 aggregated morulae were allowed to recover for 24 or 48 hours, respectively, and 
cultured on matrigel coated tissue culture plastic. Following 6 days of culture in medium 
containing 15% fetal calf serum, chimeric outgrowths were fixed and processed for 
immunofluorescence. All outgrowths were imaged using a Zeiss Pascal confocal 
microscope. 
Formation of Embryoid Bodies 
Embryoid body formation for B G N 2 cells was carried out as previously described (Sato 
et al., 2004). B G N 2 cells grown for 5 days in described conditions were harvested using 
dispase (Invitrogen) and plated on bacterial culture plates. Embryoid bodies were allowed 
to form by growth in suspension for 7 days and were photographed by light-field 
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microscopy. Embryoid bodies were then plated on gelatin coated tissue culture grade 
plastic and further cultured for 7 days in order to allow for terminal differentiation of cell 
types. Reattached and terminally differentiated embryoid bodies were harvested and 
processed by RT-PCR in order to assay for the presence of derivatives of primary germ 
layers. Embryoid bodies were generated from R U E S 1 hESCs by incubation of cultures in 
Dispase until colonies detatched from the substrate. This was followed by culture of the 
aggregates in D M E M supplemented with 20%FCS, IX penicillin-streptomycin, IX 
GlutaMAX (all from Gibco) on non-tissue culture treated Petri dishes coated with a thin 
layer of agarose to prevent attachment. 
Real time RT-PCR 
R U E S 1 hESCs were grown in feeder free conditions in the presence of MEF-conditioned 
medium. To induce differentiation, C M was withdrawn and replaced with non-
conditioned growth medium for 30 days. Real-time RT-PCR with previously published 
gene specific primer sets was performed as described (Suarez-Farinas et al., 2005). 
Briefly, Ubiquitin-C (UBC) and b-2-microglobulin were used as an internal control for 
normalization. Data were analyzed in triplicate. 
Teratoma formation 
To generate teratomas, 1-2X106 R U E S 1 hESCs were injected into the rear leg muscle of 
SCID/Beige mice. Teratomas were allowed to develop for 4-6 weeks and were then 
excised and fixed in neutral buffered formalin and analyzed histologically by trained 
pathologist. Some teratomas were fixed, equilibrated in 3 0 % sucrose and embedded for 
cryosectioning. Sections were processed immunohistochemically for markers of germ 
layers as described above. 
Karyotype analysis 
R U E S 1 hESCs were independently karyotyped after 6 passages by G-banding at 450-650 
band resolution (Cancer Genetics, Inc.) 
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Lentiviral vectors and infections 
Supernatants containing infectious particles were collecred 36 hours after calcium 
phosphate co-transfection of H E K 293 (Graham et al., 1977; Graham and van der Eb, 
1973) cells with pTrip (Sirven et al., 2000; Sirven et al., 2001), ps P A X 2 (D. Trono Swiss 
Institute of Technology Lausanne), and pL-VSV-G (Bartz and Vodicka, 1997; Yee et al., 
1994). hESCs were infected at 5 X IO5 ifu/ml. 
Statistical analysis 
Student's t-test was performed in Excel (Microsoft) to access significance of differences 
in deltaCt values between differentiated and undifferentiated samples in Real-time RT-
P C R analysis. For statistical comparisons of fold-change measurements between RT-
P C R results and previously published microarray data (Suarez-Farinas et al., 2005), 
A N O V A as well as Pearson correlation and regression analysis with two-tailed p-values 
was performed in Prism 3.0 (GraphPad Software, Inc.). 
Blastocyst injections and embryonic outgrowth culture 
R U E S 1 hESCs were manually dissected into 10-15 cells clumps using finely drawn glass 
Pasteur pipets and injected into embryonic day 3.5 mouse blastocysts flushed from the 
uterine horns of Swiss Webster mice. hESC clumps were drawn into custom pulled 
transfer pipets with a 25 urn bore (Eppendorf™) and injected into the blastocoel cavity of 
mouse embryos. hESC injected blastocysts were either fixed 24 hours post injection, or 
cultured on Matrigel™ coated tissue culture plastic in culture medium containing 1 5 % 
fetal bovine serum for 6 days. Resultant embryonic outgrowths were fixed and processed 
immunohistochemically as described above. 
RUES1 aggregation with mouse blastomere embryos 
Embryonic day 2.5 mouse embryos were flushed from the oviduct of superovulated 
CBA/B6 mice and treated with acid tyrodes to remove their zona pellucidae. In conical 
bottomed wells of a 96-well plate, one embryo was placed with a dispase-dissociated 
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hESC clump of -10-15 cells and the plate was centrifuged briefly in order to combine 
them (adapted from Nagy, 2003). Embryos were allowed to recover for 48 hours, when 
they were fixed and processed immunocytochemically as described above. Under these 
conditions, m E S C s aggregated in parallel showed contribution to host I C M after 48 
hours. 
Chimeric blastocyst implantation 
Embryonic day 3.5 mouse blastocysts that were injected with hESCs and allowed to 
recover for 6 hours post-injection were transferred to the uterine horns of pseudopregnant 
foster mice as previously described. Five days following transfer, implanted embryos 
were recovered from the uterus of foster mothers and examined for hESC contribution. 
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